rna  (Thermo Fisher)


Bioz Verified Symbol Thermo Fisher is a verified supplier
Bioz Manufacturer Symbol Thermo Fisher manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 99
    Name:
    E coli Total RNA
    Description:
    The highest quality RNA available from Ambion it is DNase treated and subjected to unsurpassed quality control standards One tube containing 200 µg is provided at a concentration of 1 mg mL The samples are processed using Ambion RNA isolation reagents to produce highly pure intact RNA A stringent DNase treatment is performed to ensure that the RNA is ready for use in any downstream application including RT PCR Note While it is impossible to remove every DNA molecule from an RNA sample each preparation is tested to ensure that any residual DNA contamination is insignificant The integrity of the RNA is verified by capillary electrophoresis using the Agilent 2100 bioanalyzer
    Catalog Number:
    AM7940
    Price:
    None
    Category:
    DNA Vectors Clones Purified Nucleic Acids Libraries
    Applications:
    DNA & RNA Purification & Analysis|Purified RNA|RNA Extraction
    Buy from Supplier


    Structured Review

    Thermo Fisher rna
    In vitro selection of <t>RNA-BP</t> cDNAs by using <t>T7</t> phage display. An RNA-BP cDNA is inserted into a T7 cloning vector and packaged in a phage capsid to generate a recombinant phage in which the RNA-BP is displayed on the surface as a carboxyl-terminal fusion to the T7 capsid protein 10B. The resulting phage is allowed to bind to the RNA bait, which itself is annealed to a biotinylated DNA oligonucleotide. RNA-bound T7 phage are captured on streptavidin-coated paramagnetic beads, separated from other members of the phage mixture with a magnet, and used to infect E. coli without prior release from the beads. After replication, the phage progeny can be subjected to additional rounds of selection.
    The highest quality RNA available from Ambion it is DNase treated and subjected to unsurpassed quality control standards One tube containing 200 µg is provided at a concentration of 1 mg mL The samples are processed using Ambion RNA isolation reagents to produce highly pure intact RNA A stringent DNase treatment is performed to ensure that the RNA is ready for use in any downstream application including RT PCR Note While it is impossible to remove every DNA molecule from an RNA sample each preparation is tested to ensure that any residual DNA contamination is insignificant The integrity of the RNA is verified by capillary electrophoresis using the Agilent 2100 bioanalyzer
    https://www.bioz.com/result/rna/product/Thermo Fisher
    Average 99 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    rna - by Bioz Stars, 2021-09
    99/100 stars

    Images

    1) Product Images from "T7 phage display: A novel genetic selection system for cloning RNA-binding proteins from cDNA libraries"

    Article Title: T7 phage display: A novel genetic selection system for cloning RNA-binding proteins from cDNA libraries

    Journal: Proceedings of the National Academy of Sciences of the United States of America

    doi: 10.1073/pnas.211439598

    In vitro selection of RNA-BP cDNAs by using T7 phage display. An RNA-BP cDNA is inserted into a T7 cloning vector and packaged in a phage capsid to generate a recombinant phage in which the RNA-BP is displayed on the surface as a carboxyl-terminal fusion to the T7 capsid protein 10B. The resulting phage is allowed to bind to the RNA bait, which itself is annealed to a biotinylated DNA oligonucleotide. RNA-bound T7 phage are captured on streptavidin-coated paramagnetic beads, separated from other members of the phage mixture with a magnet, and used to infect E. coli without prior release from the beads. After replication, the phage progeny can be subjected to additional rounds of selection.
    Figure Legend Snippet: In vitro selection of RNA-BP cDNAs by using T7 phage display. An RNA-BP cDNA is inserted into a T7 cloning vector and packaged in a phage capsid to generate a recombinant phage in which the RNA-BP is displayed on the surface as a carboxyl-terminal fusion to the T7 capsid protein 10B. The resulting phage is allowed to bind to the RNA bait, which itself is annealed to a biotinylated DNA oligonucleotide. RNA-bound T7 phage are captured on streptavidin-coated paramagnetic beads, separated from other members of the phage mixture with a magnet, and used to infect E. coli without prior release from the beads. After replication, the phage progeny can be subjected to additional rounds of selection.

    Techniques Used: In Vitro, Selection, Clone Assay, Plasmid Preparation, Recombinant

    RNA stability in phage lysates generated from different E. coli host strains. Radiolabeled U1hpII RNA (5 pmol) was mixed with either of two T7 phage lysates (5 × 10 9 pfu) prepared from E. coli BLT5615 or RNA5615 (an isogenic strain deficient in RNase I). After incubation at room temperature for the times indicated, RNA samples were analyzed by electrophoresis on a nondenaturing polyacrylamide gel.
    Figure Legend Snippet: RNA stability in phage lysates generated from different E. coli host strains. Radiolabeled U1hpII RNA (5 pmol) was mixed with either of two T7 phage lysates (5 × 10 9 pfu) prepared from E. coli BLT5615 or RNA5615 (an isogenic strain deficient in RNase I). After incubation at room temperature for the times indicated, RNA samples were analyzed by electrophoresis on a nondenaturing polyacrylamide gel.

    Techniques Used: Generated, Incubation, Electrophoresis

    2) Product Images from "Characterization of competence and biofilm development of a Streptocccus sanguinis endocarditis isolate"

    Article Title: Characterization of competence and biofilm development of a Streptocccus sanguinis endocarditis isolate

    Journal: Molecular oral microbiology

    doi: 10.1111/j.2041-1014.2010.00602.x

    RNA isolation, cDNA synthesis and real-time PCR
    Figure Legend Snippet: RNA isolation, cDNA synthesis and real-time PCR

    Techniques Used: Isolation, Real-time Polymerase Chain Reaction

    3) Product Images from "Expression of S100P and Its Novel Binding Partner S100PBPR in Early Pancreatic Cancer"

    Article Title: Expression of S100P and Its Novel Binding Partner S100PBPR in Early Pancreatic Cancer

    Journal:

    doi:

    S100PBPR expression in normal tissues. cDNAs made from RNA samples isolated from normal organs were used as templates for RT-PCR to determine the presence of S100PBPR expression. Samples were run in the following order: lane 1 , universal RNA (positive
    Figure Legend Snippet: S100PBPR expression in normal tissues. cDNAs made from RNA samples isolated from normal organs were used as templates for RT-PCR to determine the presence of S100PBPR expression. Samples were run in the following order: lane 1 , universal RNA (positive

    Techniques Used: Expressing, Isolation, Reverse Transcription Polymerase Chain Reaction

    4) Product Images from "Inhibition of HPV-16 E6/E7 immortalization of normal keratinocytes by hairpin ribozymes"

    Article Title: Inhibition of HPV-16 E6/E7 immortalization of normal keratinocytes by hairpin ribozymes

    Journal: Proceedings of the National Academy of Sciences of the United States of America

    doi:

    Cis-expression of R434 ribozyme inhibits HPV-16E6/E7 in vitro translation. ( A ) Map of HPV-16E6/E7 cis-expression constructs with R434 and R434i ribozymes. PCR-amplified fragments containing the entire HPV-16 E6/E7 genes (nucleotides 97–868) linked to R434 (pCR16E6/E7RZ) or R434i (pCR16E6/E7RZi) ribozymes were cloned in the pCR3.1 vector. The pCR16HH plasmid contains only the HPV-16E6/E7 genes. The relative positions of the Sty I sites used for cloning the ribozymes and the vector poly(A) signal are shown. ( B ) The protein products produced by plasmids pCR16HH, pCR16E6/E7RZ, and pCR16E6/E7RZi were examined by in vitro translation reactions using T7 RNA polymerase and rabbit reticulocyte lysates in the presence of [ 35 S]methionine. ←, the position of E6 and E7 proteins. Luc, luciferase protein reaction control.
    Figure Legend Snippet: Cis-expression of R434 ribozyme inhibits HPV-16E6/E7 in vitro translation. ( A ) Map of HPV-16E6/E7 cis-expression constructs with R434 and R434i ribozymes. PCR-amplified fragments containing the entire HPV-16 E6/E7 genes (nucleotides 97–868) linked to R434 (pCR16E6/E7RZ) or R434i (pCR16E6/E7RZi) ribozymes were cloned in the pCR3.1 vector. The pCR16HH plasmid contains only the HPV-16E6/E7 genes. The relative positions of the Sty I sites used for cloning the ribozymes and the vector poly(A) signal are shown. ( B ) The protein products produced by plasmids pCR16HH, pCR16E6/E7RZ, and pCR16E6/E7RZi were examined by in vitro translation reactions using T7 RNA polymerase and rabbit reticulocyte lysates in the presence of [ 35 S]methionine. ←, the position of E6 and E7 proteins. Luc, luciferase protein reaction control.

    Techniques Used: Expressing, In Vitro, Construct, Polymerase Chain Reaction, Amplification, Clone Assay, Plasmid Preparation, Produced, Luciferase

    Short term growth inhibition of HPV-16 E6/E7-transfected HKc by cis-expressed R434. ( A ) HKc were transfected with the pCR16HH, pCR16E6/E7RZ, or pCR16E6/E7RZi constructs and were kept in G418 (200 μg/ml) for 2 wk, and 10 5 cells were seeded for counting in 6-well dishes. The graphics are the mean of three experiments. ( B ) RT-PCR analysis of RNA from HKc transfected with HPV-16 E6/E7 (pCR16HH) and cis-expressed active and inactive ribozymes (pCR16E6/E7RZ and pCR16E6/E7RZi, respectively). Total RNA (1 μg) was subjected to a coupled RT-PCR reaction with primers specific to both sides of the ribozyme cleavage site as described in Material and Methods . A contamination control without reverse transcriptase (control) was included. Separate RT-PCR reactions were performed by using the same RNA sample with primers specific to the human β-actin gene to show RNA integrity. The HPV-16 E6/E7-amplified products (492 and 326 bp) were separated through agarose gel electrophoresis and visualized with ethidium bromide staining. The arrows indicate the position and size of the amplified products.
    Figure Legend Snippet: Short term growth inhibition of HPV-16 E6/E7-transfected HKc by cis-expressed R434. ( A ) HKc were transfected with the pCR16HH, pCR16E6/E7RZ, or pCR16E6/E7RZi constructs and were kept in G418 (200 μg/ml) for 2 wk, and 10 5 cells were seeded for counting in 6-well dishes. The graphics are the mean of three experiments. ( B ) RT-PCR analysis of RNA from HKc transfected with HPV-16 E6/E7 (pCR16HH) and cis-expressed active and inactive ribozymes (pCR16E6/E7RZ and pCR16E6/E7RZi, respectively). Total RNA (1 μg) was subjected to a coupled RT-PCR reaction with primers specific to both sides of the ribozyme cleavage site as described in Material and Methods . A contamination control without reverse transcriptase (control) was included. Separate RT-PCR reactions were performed by using the same RNA sample with primers specific to the human β-actin gene to show RNA integrity. The HPV-16 E6/E7-amplified products (492 and 326 bp) were separated through agarose gel electrophoresis and visualized with ethidium bromide staining. The arrows indicate the position and size of the amplified products.

    Techniques Used: Inhibition, Transfection, Construct, Reverse Transcription Polymerase Chain Reaction, Amplification, Agarose Gel Electrophoresis, Staining

    5) Product Images from "'RNA walk' a novel approach to study RNA-RNA interactions between a small RNA and its target"

    Article Title: 'RNA walk' a novel approach to study RNA-RNA interactions between a small RNA and its target

    Journal: Nucleic Acids Research

    doi: 10.1093/nar/gkp872

    Affinity selection of sRNA-85 in untreated and AMT UV crossed-linked cells. ( A ) Total RNA was prepared from L. collosoma cells (5 × 10 9 ) and subjected to affinity selection using 2′- O -methyl biotinylated oligonucleotide of sRNA-85 as described in ‘Materials and Methods’ section. The affinity-selected product (‘affinity’) and 10% of the total RNA (T) was subjected to primer extension with radiolabeled oligonucleotides complementary to sRNA-85 (lanes 1 and 2) or tRNA Arg (lanes 3 and 4) and separated on a 6% denaturating gel. ( B ) Cells were treated with 0.2 mg ml− 1 AMT, and irradiated at 365 nm with UV light (10 milliWatts cm −2 ) for 60 min. RNA from the same number of irradiated (+; lane 2) or untreated (−; lane 1) cells was subjected to primer extension and separated on a 6% denaturing gel. ( C ) Total RNA from irradiated cells was subjected to either one round (lanes 2 and 5) or two rounds (lanes 3 and 6) of affinity selection and primer extension was preformed with oligonucleotides specific to sRNA-85 and srRNA-2, and compared with 10% of the total RNA used for selection (lanes 1 and 4). ( D ) RNA was prepared from irradiated cells and from control untreated cells as described above. The RNA (from 10 10 cells) was subjected to affinity selection as described in ‘Materials and Methods’ section. The affinity-selected products (lanes 2 and 3) and 2 µg total RNA (lane 1) were subjected to reverse transcription using random primers. The cDNA was amplified by PCR using primers for snoRNA-2. The PCR products were separated on 1.5% agarose gel and detected by ethidium bromide staining.
    Figure Legend Snippet: Affinity selection of sRNA-85 in untreated and AMT UV crossed-linked cells. ( A ) Total RNA was prepared from L. collosoma cells (5 × 10 9 ) and subjected to affinity selection using 2′- O -methyl biotinylated oligonucleotide of sRNA-85 as described in ‘Materials and Methods’ section. The affinity-selected product (‘affinity’) and 10% of the total RNA (T) was subjected to primer extension with radiolabeled oligonucleotides complementary to sRNA-85 (lanes 1 and 2) or tRNA Arg (lanes 3 and 4) and separated on a 6% denaturating gel. ( B ) Cells were treated with 0.2 mg ml− 1 AMT, and irradiated at 365 nm with UV light (10 milliWatts cm −2 ) for 60 min. RNA from the same number of irradiated (+; lane 2) or untreated (−; lane 1) cells was subjected to primer extension and separated on a 6% denaturing gel. ( C ) Total RNA from irradiated cells was subjected to either one round (lanes 2 and 5) or two rounds (lanes 3 and 6) of affinity selection and primer extension was preformed with oligonucleotides specific to sRNA-85 and srRNA-2, and compared with 10% of the total RNA used for selection (lanes 1 and 4). ( D ) RNA was prepared from irradiated cells and from control untreated cells as described above. The RNA (from 10 10 cells) was subjected to affinity selection as described in ‘Materials and Methods’ section. The affinity-selected products (lanes 2 and 3) and 2 µg total RNA (lane 1) were subjected to reverse transcription using random primers. The cDNA was amplified by PCR using primers for snoRNA-2. The PCR products were separated on 1.5% agarose gel and detected by ethidium bromide staining.

    Techniques Used: Selection, Irradiation, Amplification, Polymerase Chain Reaction, Agarose Gel Electrophoresis, Staining

    Quantitative real-time PCR analysis of the ‘RNA Walk’ method. Real-time PCR was performed as described in ‘Materials and Methods’ section using cDNA (diluted 1:100 000). Concentration curves were prepared for each domain studied. The curves were used to determine the amount of PCR product amplified from each domain. PCR was performed on DNA prepared from RNA extracted from non-irradiated cells (−UV, gray bars) and from irradiated cells (+UV, black bars). The different rRNA domains examined are indicated and depicted schematically underneath the graph.
    Figure Legend Snippet: Quantitative real-time PCR analysis of the ‘RNA Walk’ method. Real-time PCR was performed as described in ‘Materials and Methods’ section using cDNA (diluted 1:100 000). Concentration curves were prepared for each domain studied. The curves were used to determine the amount of PCR product amplified from each domain. PCR was performed on DNA prepared from RNA extracted from non-irradiated cells (−UV, gray bars) and from irradiated cells (+UV, black bars). The different rRNA domains examined are indicated and depicted schematically underneath the graph.

    Techniques Used: Real-time Polymerase Chain Reaction, Concentration Assay, Polymerase Chain Reaction, Amplification, Irradiation

    Identification of the regions where the rRNA interacts with sRNA-85 by the ‘RNA walk’ method. ( A ) Schematic representation of the ‘RNA walk’ approach. Cells were treated with AMT and subjected to UV irradiation; RNA was then prepared by deproteinization and Trizol reagent extraction. RNA was then subjected to affinity selection with anti-sense biotinylated oligonucleotide complementary to sRNA-85. cDNA was prepared from the affinity-selected RNA, and amplified by PCR using primers covering the entire rRNA target. ( B ) PCR analyses of cDNA covering the rRNA. RNA was prepared from irradiated cells and from control untreated cells as described in Figure 1 . The RNA (from 10 10 cells) was subjected to affinity selection as described in ‘Materials and Methods’ section. The affinity-selected product was subjected to reverse transcription using random primers. The cDNA was amplified by PCR using primers dividing the rRNA into 12 ∼500nt domains spanning the entire rRNA. The PCR products were separated on 1.5% agarose gel and detected by ethidium bromide staining. RNA from irradiated and untreated cells is designated by (+) and (−), respectively. The positions of the PCR domains are marked by double-headed arrows on the rRNA subunits (indicated). Stars mark the domains carrying the cross-linked adducts. ( C ) ‘RNA Walk’ using an internal control. ‘RNA walk’ was performed with affinity-selected RNA prepared from irradiated cells (+UV) or non-irradiated cells (−UV). The RNA was spiked with 100 ng of synthetic RNA ( in vitro transcribed luciferase). cDNA was prepared as described in (B) and PCR was performed using primers that amplify the rRNA domain (listed above the lanes) and luciferase mRNA in the same reaction. ( D ) Photoreversal of cross-linking eliminates the block of reverse transcriptase and enables PCR amplification of the cDNA. cDNA was prepared from affinity-selected RNA derived from irradiated cells (lane 2), from untreated cells (lane 1) and from affinity-selected RNA that was photo reversed (lanes 3 and 4). PCR amplification was performed with primers specific to domain 12. ( E ) RNA walk requires both UV and AMT. cDNA was prepared with random primers from affinity-selected RNA derived from untreated cells (lane 1), and cells irradiated in the presence (lane 2) and absence (lane 3) of AMT. PCR amplification was performed with primers specific to domain 12. ( F ) RNA walk stop is confirmed using specific primers. cDNA was prepared from affinity selected (lanes 2 and 4) and total RNA (lanes 1 and 3) from untreated and irradiated cells using a gene specific primer (primer LCLSUβ560AS). PCR amplification was preformed with primers specific to domain 12.
    Figure Legend Snippet: Identification of the regions where the rRNA interacts with sRNA-85 by the ‘RNA walk’ method. ( A ) Schematic representation of the ‘RNA walk’ approach. Cells were treated with AMT and subjected to UV irradiation; RNA was then prepared by deproteinization and Trizol reagent extraction. RNA was then subjected to affinity selection with anti-sense biotinylated oligonucleotide complementary to sRNA-85. cDNA was prepared from the affinity-selected RNA, and amplified by PCR using primers covering the entire rRNA target. ( B ) PCR analyses of cDNA covering the rRNA. RNA was prepared from irradiated cells and from control untreated cells as described in Figure 1 . The RNA (from 10 10 cells) was subjected to affinity selection as described in ‘Materials and Methods’ section. The affinity-selected product was subjected to reverse transcription using random primers. The cDNA was amplified by PCR using primers dividing the rRNA into 12 ∼500nt domains spanning the entire rRNA. The PCR products were separated on 1.5% agarose gel and detected by ethidium bromide staining. RNA from irradiated and untreated cells is designated by (+) and (−), respectively. The positions of the PCR domains are marked by double-headed arrows on the rRNA subunits (indicated). Stars mark the domains carrying the cross-linked adducts. ( C ) ‘RNA Walk’ using an internal control. ‘RNA walk’ was performed with affinity-selected RNA prepared from irradiated cells (+UV) or non-irradiated cells (−UV). The RNA was spiked with 100 ng of synthetic RNA ( in vitro transcribed luciferase). cDNA was prepared as described in (B) and PCR was performed using primers that amplify the rRNA domain (listed above the lanes) and luciferase mRNA in the same reaction. ( D ) Photoreversal of cross-linking eliminates the block of reverse transcriptase and enables PCR amplification of the cDNA. cDNA was prepared from affinity-selected RNA derived from irradiated cells (lane 2), from untreated cells (lane 1) and from affinity-selected RNA that was photo reversed (lanes 3 and 4). PCR amplification was performed with primers specific to domain 12. ( E ) RNA walk requires both UV and AMT. cDNA was prepared with random primers from affinity-selected RNA derived from untreated cells (lane 1), and cells irradiated in the presence (lane 2) and absence (lane 3) of AMT. PCR amplification was performed with primers specific to domain 12. ( F ) RNA walk stop is confirmed using specific primers. cDNA was prepared from affinity selected (lanes 2 and 4) and total RNA (lanes 1 and 3) from untreated and irradiated cells using a gene specific primer (primer LCLSUβ560AS). PCR amplification was preformed with primers specific to domain 12.

    Techniques Used: Irradiation, Selection, Amplification, Polymerase Chain Reaction, Agarose Gel Electrophoresis, Staining, In Vitro, Luciferase, Blocking Assay, Derivative Assay

    ‘RNA walk’ of mutant sRNA-85 lacking the anti-codon loop. ( A ) Schematic representation of deletion mutation introduced in the sRNA-85. The deletion is indicated by a box. ( B ) Northern analysis of cells carrying the sRNA-85 mutation. The blot was probed with anti-sense oligonucleotide (18288), specific to sRNA-85 that recognizes both wild-type and mutant transcripts. ( C ) Distribution of wild-type and mutant sRNA-85 on RNP particles. Low-salt extracts from cells carrying the mutation in sRNA-85 were layered on continuous 10–30% sucrose gradients containing 100 mM KCl. Gradients were centrifuged for 3 h at 35 000 rpm using SW41 rotor, as described in ‘Materials and Methods’ section. RNA prepared from the sucrose gradient fractions was subjected to northern analysis and the blot was hybridized with the same probe as in (B). S values were determined using standards, i.e. 30, 50 and 70 ribosomes from E. coli and enzyme catalase (10S). The fractions are numbered from top to bottom. The positions of the wild-type and mutated RNA are indicated. Upper panel―long exposure, Lower panel―short exposure. ( D ) Affinity selection of mutant sRNA-85. RNA was prepared from irradiated cells expressing the sRNA-85 mutant as described previously. The RNA (from 10 10 cells) was subjected to affinity selection as described in ‘Materials and Methods’ section. RNA from affinity selected and from total RNA was subjected to primer extension and the products were separated on a 6% polyacrylamide denaturing gel. ( E ) ‘RNA walk’ analysis of sRNA-85 mutant. RNA was prepared from irradiated cells and from control untreated cells expressing the sRNA-85 mutant as described in Figures 1–3. The RNA (from 10 10 cells) was subjected to affinity selection as described in ‘Materials and Methods’ section. The affinity-selected product was subjected to reverse transcription using random primers. The cDNA was amplified by PCR using the primer pairs shown. The PCR products were separated on 1.5% agarose gel and detected by ethidium bromide staining. RNA from irradiated and untreated cells is designated by (+) and (−), respectively. The positions of the PCR domains are marked by double-headed arrows on the rRNA subunits (indicated). Stars mark the domains carrying the cross-linked adducts.
    Figure Legend Snippet: ‘RNA walk’ of mutant sRNA-85 lacking the anti-codon loop. ( A ) Schematic representation of deletion mutation introduced in the sRNA-85. The deletion is indicated by a box. ( B ) Northern analysis of cells carrying the sRNA-85 mutation. The blot was probed with anti-sense oligonucleotide (18288), specific to sRNA-85 that recognizes both wild-type and mutant transcripts. ( C ) Distribution of wild-type and mutant sRNA-85 on RNP particles. Low-salt extracts from cells carrying the mutation in sRNA-85 were layered on continuous 10–30% sucrose gradients containing 100 mM KCl. Gradients were centrifuged for 3 h at 35 000 rpm using SW41 rotor, as described in ‘Materials and Methods’ section. RNA prepared from the sucrose gradient fractions was subjected to northern analysis and the blot was hybridized with the same probe as in (B). S values were determined using standards, i.e. 30, 50 and 70 ribosomes from E. coli and enzyme catalase (10S). The fractions are numbered from top to bottom. The positions of the wild-type and mutated RNA are indicated. Upper panel―long exposure, Lower panel―short exposure. ( D ) Affinity selection of mutant sRNA-85. RNA was prepared from irradiated cells expressing the sRNA-85 mutant as described previously. The RNA (from 10 10 cells) was subjected to affinity selection as described in ‘Materials and Methods’ section. RNA from affinity selected and from total RNA was subjected to primer extension and the products were separated on a 6% polyacrylamide denaturing gel. ( E ) ‘RNA walk’ analysis of sRNA-85 mutant. RNA was prepared from irradiated cells and from control untreated cells expressing the sRNA-85 mutant as described in Figures 1–3. The RNA (from 10 10 cells) was subjected to affinity selection as described in ‘Materials and Methods’ section. The affinity-selected product was subjected to reverse transcription using random primers. The cDNA was amplified by PCR using the primer pairs shown. The PCR products were separated on 1.5% agarose gel and detected by ethidium bromide staining. RNA from irradiated and untreated cells is designated by (+) and (−), respectively. The positions of the PCR domains are marked by double-headed arrows on the rRNA subunits (indicated). Stars mark the domains carrying the cross-linked adducts.

    Techniques Used: Mutagenesis, Northern Blot, Selection, Irradiation, Expressing, Amplification, Polymerase Chain Reaction, Agarose Gel Electrophoresis, Staining

    6) Product Images from "DEspR Roles in Tumor Vasculo-Angiogenesis, Invasiveness, CSC-Survival and Anoikis Resistance: A 'Common Receptor Coordinator' Paradigm"

    Article Title: DEspR Roles in Tumor Vasculo-Angiogenesis, Invasiveness, CSC-Survival and Anoikis Resistance: A 'Common Receptor Coordinator' Paradigm

    Journal: PLoS ONE

    doi: 10.1371/journal.pone.0085821

    DEspR expression and roles in Panc1-CSCs and U87-CSCs. (A) FACS analysis of anchorage-independent Panc1-CSCs and U87-CSCs comparing control double isotype immunophenotyping (IgG2b-AF568 for 7c5b2 and IgG1-AF488 for CD133) with double anti-DEspR-AF568 and anti-CD133-AF488 immunophenotyping. (B) B-i. ARMS assay specific for spliced DEspR-RNA 270-bp amplicon (red arrow) spanning the spliced exon-to-exon junction ( Figure S4B ,C) confirms presence of spliced DEspR-RNA in Panc1 (lane 1) and U87 (lane 2) CSCs. B-ii. Quantitative RT-PCR Ct plot. B-iii. Corresponding agarose-gel size fractionation of RT-PCR products demonstrating expected-size DEspR-specific 88-bp amplicon, and control cyclophilin-specific 145-bp amplicon band. DNA size standards: 50-bp DNA ladder). B-iv. Calculation of qRT-PCR ΔCt fold-change in both Panc1- and U87-anchorage independent CSCs. B-v. Western blot analysis detects predicted ∼10 kDa DEspR protein (red arrow) in membrane proteins isolated from U87 CSCs in three independent experimental conditions: 1X, 1∶100 anti-DEspR ab-dilution in two different detection systems; 2X, 1∶50 dilution of anti-DEspR mAb in ECL detection system. (C) Analysis of survival in adverse conditions comparing Panc1- (red open circle) and U87- (blue open square) nonCSCs with quinary CSCs: Panc1 (red circle) and U87 (blue square). Analysis of effects of anti-DEspR (7c5b2) treatment on U87-CSC survival measured as %-live CSCs comparing quinary 7c5b2-treated U87-CSCs (black open circle) and control non-treated U87-CSCs (black circle) in identical adverse conditions. (D) Analysis of effects of DEspR-inhibition on Panc1- and U87-CSC survival in suspension culture at physiological conditions measured as number of live cells and % dead cells comparing quinary anchorage-independent 7c5b2-treated CSCs (black bars) and control non-treated CSCs (white bars). ANOVA P
    Figure Legend Snippet: DEspR expression and roles in Panc1-CSCs and U87-CSCs. (A) FACS analysis of anchorage-independent Panc1-CSCs and U87-CSCs comparing control double isotype immunophenotyping (IgG2b-AF568 for 7c5b2 and IgG1-AF488 for CD133) with double anti-DEspR-AF568 and anti-CD133-AF488 immunophenotyping. (B) B-i. ARMS assay specific for spliced DEspR-RNA 270-bp amplicon (red arrow) spanning the spliced exon-to-exon junction ( Figure S4B ,C) confirms presence of spliced DEspR-RNA in Panc1 (lane 1) and U87 (lane 2) CSCs. B-ii. Quantitative RT-PCR Ct plot. B-iii. Corresponding agarose-gel size fractionation of RT-PCR products demonstrating expected-size DEspR-specific 88-bp amplicon, and control cyclophilin-specific 145-bp amplicon band. DNA size standards: 50-bp DNA ladder). B-iv. Calculation of qRT-PCR ΔCt fold-change in both Panc1- and U87-anchorage independent CSCs. B-v. Western blot analysis detects predicted ∼10 kDa DEspR protein (red arrow) in membrane proteins isolated from U87 CSCs in three independent experimental conditions: 1X, 1∶100 anti-DEspR ab-dilution in two different detection systems; 2X, 1∶50 dilution of anti-DEspR mAb in ECL detection system. (C) Analysis of survival in adverse conditions comparing Panc1- (red open circle) and U87- (blue open square) nonCSCs with quinary CSCs: Panc1 (red circle) and U87 (blue square). Analysis of effects of anti-DEspR (7c5b2) treatment on U87-CSC survival measured as %-live CSCs comparing quinary 7c5b2-treated U87-CSCs (black open circle) and control non-treated U87-CSCs (black circle) in identical adverse conditions. (D) Analysis of effects of DEspR-inhibition on Panc1- and U87-CSC survival in suspension culture at physiological conditions measured as number of live cells and % dead cells comparing quinary anchorage-independent 7c5b2-treated CSCs (black bars) and control non-treated CSCs (white bars). ANOVA P

    Techniques Used: Expressing, FACS, Amplification, Quantitative RT-PCR, Agarose Gel Electrophoresis, Fractionation, Reverse Transcription Polymerase Chain Reaction, Western Blot, Isolation, Inhibition

    DEspR expression and roles in Panc1-CSCs and U87-CSCs. (A) FACS analysis of anchorage-independent Panc1-CSCs and U87-CSCs comparing control double isotype immunophenotyping (IgG2b-AF568 for 7c5b2 and IgG1-AF488 for CD133) with double anti-DEspR-AF568 and anti-CD133-AF488 immunophenotyping. (B) B-i. ARMS assay specific for spliced DEspR-RNA 270-bp amplicon (red arrow) spanning the spliced exon-to-exon junction ( Figure S4B ,C) confirms presence of spliced DEspR-RNA in Panc1 (lane 1) and U87 (lane 2) CSCs. B-ii. Quantitative RT-PCR Ct plot. B-iii. Corresponding agarose-gel size fractionation of RT-PCR products demonstrating expected-size DEspR-specific 88-bp amplicon, and control cyclophilin-specific 145-bp amplicon band. DNA size standards: 50-bp DNA ladder). B-iv. Calculation of qRT-PCR ΔCt fold-change in both Panc1- and U87-anchorage independent CSCs. B-v. Western blot analysis detects predicted ∼10 kDa DEspR protein (red arrow) in membrane proteins isolated from U87 CSCs in three independent experimental conditions: 1X, 1∶100 anti-DEspR ab-dilution in two different detection systems; 2X, 1∶50 dilution of anti-DEspR mAb in ECL detection system. (C) Analysis of survival in adverse conditions comparing Panc1- (red open circle) and U87- (blue open square) nonCSCs with quinary CSCs: Panc1 (red circle) and U87 (blue square). Analysis of effects of anti-DEspR (7c5b2) treatment on U87-CSC survival measured as %-live CSCs comparing quinary 7c5b2-treated U87-CSCs (black open circle) and control non-treated U87-CSCs (black circle) in identical adverse conditions. (D) Analysis of effects of DEspR-inhibition on Panc1- and U87-CSC survival in suspension culture at physiological conditions measured as number of live cells and % dead cells comparing quinary anchorage-independent 7c5b2-treated CSCs (black bars) and control non-treated CSCs (white bars). ANOVA P
    Figure Legend Snippet: DEspR expression and roles in Panc1-CSCs and U87-CSCs. (A) FACS analysis of anchorage-independent Panc1-CSCs and U87-CSCs comparing control double isotype immunophenotyping (IgG2b-AF568 for 7c5b2 and IgG1-AF488 for CD133) with double anti-DEspR-AF568 and anti-CD133-AF488 immunophenotyping. (B) B-i. ARMS assay specific for spliced DEspR-RNA 270-bp amplicon (red arrow) spanning the spliced exon-to-exon junction ( Figure S4B ,C) confirms presence of spliced DEspR-RNA in Panc1 (lane 1) and U87 (lane 2) CSCs. B-ii. Quantitative RT-PCR Ct plot. B-iii. Corresponding agarose-gel size fractionation of RT-PCR products demonstrating expected-size DEspR-specific 88-bp amplicon, and control cyclophilin-specific 145-bp amplicon band. DNA size standards: 50-bp DNA ladder). B-iv. Calculation of qRT-PCR ΔCt fold-change in both Panc1- and U87-anchorage independent CSCs. B-v. Western blot analysis detects predicted ∼10 kDa DEspR protein (red arrow) in membrane proteins isolated from U87 CSCs in three independent experimental conditions: 1X, 1∶100 anti-DEspR ab-dilution in two different detection systems; 2X, 1∶50 dilution of anti-DEspR mAb in ECL detection system. (C) Analysis of survival in adverse conditions comparing Panc1- (red open circle) and U87- (blue open square) nonCSCs with quinary CSCs: Panc1 (red circle) and U87 (blue square). Analysis of effects of anti-DEspR (7c5b2) treatment on U87-CSC survival measured as %-live CSCs comparing quinary 7c5b2-treated U87-CSCs (black open circle) and control non-treated U87-CSCs (black circle) in identical adverse conditions. (D) Analysis of effects of DEspR-inhibition on Panc1- and U87-CSC survival in suspension culture at physiological conditions measured as number of live cells and % dead cells comparing quinary anchorage-independent 7c5b2-treated CSCs (black bars) and control non-treated CSCs (white bars). ANOVA P

    Techniques Used: Expressing, FACS, Amplification, Quantitative RT-PCR, Agarose Gel Electrophoresis, Fractionation, Reverse Transcription Polymerase Chain Reaction, Western Blot, Isolation, Inhibition

    7) Product Images from "Show me your secret(ed) weapons: a multifaceted approach reveals a wide arsenal of type III‐secreted effectors in the cucurbit pathogenic bacterium Acidovorax citrulli and novel effectors in the Acidovorax genus"

    Article Title: Show me your secret(ed) weapons: a multifaceted approach reveals a wide arsenal of type III‐secreted effectors in the cucurbit pathogenic bacterium Acidovorax citrulli and novel effectors in the Acidovorax genus

    Journal: Molecular Plant Pathology

    doi: 10.1111/mpp.12877

    HrpX is required for pathogenicity and regulates expression of T3S and T3E genes in Acidovorax citrulli M6. (A) Disease lesions produced in a melon leaf inoculated with wild‐type M6, but not with mutant strains defective in hrpX or hrcV (encoding a core component of the T3SS) genes. The picture was taken at 3 days after inoculation (dai). (B) Cell death observed in a pepper leaf following inoculation with wild‐type M6, but not with hrpX and hrcV mutants. The picture was taken at 4 dai. In (A) and (B), leaves were syringe‐infiltrated with a bacterial suspension of 10 8 cfu/mL. (C) Qualitative assessment of differential gene expression between wild‐type M6 and the M6 hrpX mutant after 72 h of growth in XVM2 minimal medium at 28 °C. gDNA, genomic DNA. cDNA, reverse‐trancriptase (RT)‐PCR of RNA extracts. Genes: hrcV ( APS58_2306 ), hrcT ( APS58_2309 ), hrcJ ( APS58_2321 ) and hrcC ( APS58_2331 ), encoding core T3SS components; APS58_3289 , encoding a T3E similar to Pseudomonas syringae hopW1‐1 ; GAPDH , glyceraldehyde‐3‐phosphate dehydrogenase ( APS58_1610 ; control).
    Figure Legend Snippet: HrpX is required for pathogenicity and regulates expression of T3S and T3E genes in Acidovorax citrulli M6. (A) Disease lesions produced in a melon leaf inoculated with wild‐type M6, but not with mutant strains defective in hrpX or hrcV (encoding a core component of the T3SS) genes. The picture was taken at 3 days after inoculation (dai). (B) Cell death observed in a pepper leaf following inoculation with wild‐type M6, but not with hrpX and hrcV mutants. The picture was taken at 4 dai. In (A) and (B), leaves were syringe‐infiltrated with a bacterial suspension of 10 8 cfu/mL. (C) Qualitative assessment of differential gene expression between wild‐type M6 and the M6 hrpX mutant after 72 h of growth in XVM2 minimal medium at 28 °C. gDNA, genomic DNA. cDNA, reverse‐trancriptase (RT)‐PCR of RNA extracts. Genes: hrcV ( APS58_2306 ), hrcT ( APS58_2309 ), hrcJ ( APS58_2321 ) and hrcC ( APS58_2331 ), encoding core T3SS components; APS58_3289 , encoding a T3E similar to Pseudomonas syringae hopW1‐1 ; GAPDH , glyceraldehyde‐3‐phosphate dehydrogenase ( APS58_1610 ; control).

    Techniques Used: Expressing, Produced, Mutagenesis, Reverse Transcription Polymerase Chain Reaction

    8) Product Images from "Heat shock protein 90 inhibition abrogates TLR4-mediated NF-κB activity and reduces renal ischemia-reperfusion injury"

    Article Title: Heat shock protein 90 inhibition abrogates TLR4-mediated NF-κB activity and reduces renal ischemia-reperfusion injury

    Journal: Scientific Reports

    doi: 10.1038/srep12958

    Renal TLR4 expression following AT13387 or vehicle pre-treatment and 24 h following renal IRI in FVB/n mice. FVB/n mice were pre-treated with AT13387 or 2HβC vehicle (n = 6 per group) and underwent renal IRI as per Fig. 1 . The left kidney was harvested and stored in RNAlater for 24 h before being frozen. RNA was later extracted and converted to cDNA. PCR was then performed to determine TLR4 expression. TLR4 expression was normalised to GAPDH expression. Results are presented in a standard boxplot with individual results jittered. **p
    Figure Legend Snippet: Renal TLR4 expression following AT13387 or vehicle pre-treatment and 24 h following renal IRI in FVB/n mice. FVB/n mice were pre-treated with AT13387 or 2HβC vehicle (n = 6 per group) and underwent renal IRI as per Fig. 1 . The left kidney was harvested and stored in RNAlater for 24 h before being frozen. RNA was later extracted and converted to cDNA. PCR was then performed to determine TLR4 expression. TLR4 expression was normalised to GAPDH expression. Results are presented in a standard boxplot with individual results jittered. **p

    Techniques Used: Expressing, Mouse Assay, Polymerase Chain Reaction

    9) Product Images from "Transcriptome Analysis Reveals Altered Expression of Memory and Neurotransmission Associated Genes in the REM Sleep Deprived Rat Brain"

    Article Title: Transcriptome Analysis Reveals Altered Expression of Memory and Neurotransmission Associated Genes in the REM Sleep Deprived Rat Brain

    Journal: Frontiers in Molecular Neuroscience

    doi: 10.3389/fnmol.2017.00067

    Na–K ATPase activity and expression: (A) Na–K ATPase activity in synaptosomes prepared from rat brains ( n = 4 rats per groups). (B) RNA seq data showing significant up-regulation of ATP1B2 transcripts upon REMSD ( P
    Figure Legend Snippet: Na–K ATPase activity and expression: (A) Na–K ATPase activity in synaptosomes prepared from rat brains ( n = 4 rats per groups). (B) RNA seq data showing significant up-regulation of ATP1B2 transcripts upon REMSD ( P

    Techniques Used: Activity Assay, Expressing, RNA Sequencing Assay

    Validation of rat brain RNA seq data using different controls. Some genes were selected for validation of RNA seq data by qRT-PCR. (A) RNA sequencing results (log 10 FPKM values) showing DEGs involved in sleep and neuronal regulation like OXT, RMRP, LNPEP, AVP, HIST2H4, GRIN2B, PMCH and HCRT were down regulated upon REMSD. Other set of genes up regulated upon REMSD, which includes DBH, NPAS4, EGR1 and SYT2. For validation of these RNA seq results, we have included other additional controls like large platform control (Lrg Plat), recovery control (Rec Ctrl) and Prazosin treatment group (PRZ treated). (B–M) Shows qRT-PCR results for above genes in free moving control (Free Mov), large platform control (Lrg Ctrl), REMSD, recovery control (Rec Ctrl), Prazosin treatment group (PRZ treated) ( n = 5 per group). Statistical analyses were performed using one-way ANOVA followed by Newman–Keuls multiple comparison tests. Data are expressed as the mean ± SEM ( ∗ P
    Figure Legend Snippet: Validation of rat brain RNA seq data using different controls. Some genes were selected for validation of RNA seq data by qRT-PCR. (A) RNA sequencing results (log 10 FPKM values) showing DEGs involved in sleep and neuronal regulation like OXT, RMRP, LNPEP, AVP, HIST2H4, GRIN2B, PMCH and HCRT were down regulated upon REMSD. Other set of genes up regulated upon REMSD, which includes DBH, NPAS4, EGR1 and SYT2. For validation of these RNA seq results, we have included other additional controls like large platform control (Lrg Plat), recovery control (Rec Ctrl) and Prazosin treatment group (PRZ treated). (B–M) Shows qRT-PCR results for above genes in free moving control (Free Mov), large platform control (Lrg Ctrl), REMSD, recovery control (Rec Ctrl), Prazosin treatment group (PRZ treated) ( n = 5 per group). Statistical analyses were performed using one-way ANOVA followed by Newman–Keuls multiple comparison tests. Data are expressed as the mean ± SEM ( ∗ P

    Techniques Used: RNA Sequencing Assay, Quantitative RT-PCR

    10) Product Images from "Oral and Vaginal Epithelial Cell Lines Bind and Transfer Cell-Free Infectious HIV-1 to Permissive Cells but Are Not Productively Infected"

    Article Title: Oral and Vaginal Epithelial Cell Lines Bind and Transfer Cell-Free Infectious HIV-1 to Permissive Cells but Are Not Productively Infected

    Journal: PLoS ONE

    doi: 10.1371/journal.pone.0098077

    Different methods used to detect HIV-1 R5 and X4 binding to epithelial cells. (A) Post-lysis detection of p24 gag protein by Western blotting. Primary (gingival) epithelial cells, TR146, FaDu, A431 and TZM-bl cells were incubated overnight (16–24 h) with cell free YU2 (R5) or LAI (X4). After extensive washing to remove unbound virus, normalised total protein lysates were separated by SDS-PAGE and probed for HIV p24 using α-actin as a loading control. (B) Detection of immobilized virus on the cell surface by flow cytometry. Epithelial cells were incubated overnight with cell free virus. Bound virus was detected using a Cy5-labeled anti-human secondary antibody to detect HIV-1 gp120 primary monoclonal on the APC channel. Electronic gates were set around an unlabelled cell control, this area is then set as zero and any cells shifted to the right of the gate are deemed positive. To determine amount of virus bound, virally exposed, labelled cell percentages are subtracted from the uninfected (unexposed) labelled control cell percentages to obtain the % fluorescence values shown. Data are representative of four independent experiments and bars indicate ± standard deviation from the mean. (C) Detection of packaged HIV R5 RNA by amplification of the HIV-1 pol gene using nested PCR. Total RNA was extracted from TR146, FaDu, A431 and TZM-bl cells incubated overnight with cell free YU2 (R5) and used to produce viral cDNA. This was then used as a template in a nested PCR to detect a 2 Kb region of HIV pol. (D) Percentage reduction in detection of immobilized virus on the cell surface by flow cytometry after trypsin treatment. Virally exposed cells are compared with cells labelled with secondary antibody alone. Data set is representative of three independent experiments. * = P
    Figure Legend Snippet: Different methods used to detect HIV-1 R5 and X4 binding to epithelial cells. (A) Post-lysis detection of p24 gag protein by Western blotting. Primary (gingival) epithelial cells, TR146, FaDu, A431 and TZM-bl cells were incubated overnight (16–24 h) with cell free YU2 (R5) or LAI (X4). After extensive washing to remove unbound virus, normalised total protein lysates were separated by SDS-PAGE and probed for HIV p24 using α-actin as a loading control. (B) Detection of immobilized virus on the cell surface by flow cytometry. Epithelial cells were incubated overnight with cell free virus. Bound virus was detected using a Cy5-labeled anti-human secondary antibody to detect HIV-1 gp120 primary monoclonal on the APC channel. Electronic gates were set around an unlabelled cell control, this area is then set as zero and any cells shifted to the right of the gate are deemed positive. To determine amount of virus bound, virally exposed, labelled cell percentages are subtracted from the uninfected (unexposed) labelled control cell percentages to obtain the % fluorescence values shown. Data are representative of four independent experiments and bars indicate ± standard deviation from the mean. (C) Detection of packaged HIV R5 RNA by amplification of the HIV-1 pol gene using nested PCR. Total RNA was extracted from TR146, FaDu, A431 and TZM-bl cells incubated overnight with cell free YU2 (R5) and used to produce viral cDNA. This was then used as a template in a nested PCR to detect a 2 Kb region of HIV pol. (D) Percentage reduction in detection of immobilized virus on the cell surface by flow cytometry after trypsin treatment. Virally exposed cells are compared with cells labelled with secondary antibody alone. Data set is representative of three independent experiments. * = P

    Techniques Used: Binding Assay, Lysis, Western Blot, Incubation, SDS Page, Flow Cytometry, Cytometry, Labeling, Fluorescence, Standard Deviation, Amplification, Nested PCR

    Post-integration HIV-1 mRNA transcription and de novo viral protein production in epithelial cells (MOI: 0.2). (A) Detection of spliced HIV-1 tat mRNA in TR146, FaDu, A431 and TZM-bl control cells by PCR 24 h post-infection with YU2 (R5) or LAI (X4) infectious virus. Equal amounts of total RNA was used to synthesise viral cDNA which was then subjected to PCR using primers designed to span the TAT 1 and 2 exon junctions. (B) p55 gag protein detection in TR146, FaDu, A431 and TZM-bl control cells by Western blot after 24 h infection with R5 (YU2) and LAI (X4) virus. (C) Infection of TR146, FaDu, A431 and NP2-R5/X4 control cells with GFP-linked single-cycle X4, R5 and dual tropic HIV-1 gp160 pseudotyped virus and detection of GFP incorporation into epithelial cell DNA by flow cytometry. Error bars show standard error from the mean. Data are representative of three independent experiments.
    Figure Legend Snippet: Post-integration HIV-1 mRNA transcription and de novo viral protein production in epithelial cells (MOI: 0.2). (A) Detection of spliced HIV-1 tat mRNA in TR146, FaDu, A431 and TZM-bl control cells by PCR 24 h post-infection with YU2 (R5) or LAI (X4) infectious virus. Equal amounts of total RNA was used to synthesise viral cDNA which was then subjected to PCR using primers designed to span the TAT 1 and 2 exon junctions. (B) p55 gag protein detection in TR146, FaDu, A431 and TZM-bl control cells by Western blot after 24 h infection with R5 (YU2) and LAI (X4) virus. (C) Infection of TR146, FaDu, A431 and NP2-R5/X4 control cells with GFP-linked single-cycle X4, R5 and dual tropic HIV-1 gp160 pseudotyped virus and detection of GFP incorporation into epithelial cell DNA by flow cytometry. Error bars show standard error from the mean. Data are representative of three independent experiments.

    Techniques Used: Polymerase Chain Reaction, Infection, Western Blot, Flow Cytometry, Cytometry

    11) Product Images from "Resveratrol modulates the levels of microRNAs targeting genes encoding tumor-suppressors and effectors of TGF? signaling pathway in SW480 cells"

    Article Title: Resveratrol modulates the levels of microRNAs targeting genes encoding tumor-suppressors and effectors of TGF? signaling pathway in SW480 cells

    Journal: Biochemical pharmacology

    doi: 10.1016/j.bcp.2010.07.003

    MiR-663 targets TGFβ1 transcripts (A) Schematic representation (not to scale) of the 307 nt-long 3′-untranslated region of TGFβ1 transcripts. The positions of the two sets of overlapping miR-663 target sites (TS1 to TS5) are given in nucleotides. Their sequences (CCCCGCC) are given in black boxes. Nucleotides modified in the two single mutant constructs ( Luc- TGFβ-M663-1 and Luc- TGFβ-M663-2 ) are given below the figure (dashes correspond to conserved nucleotides). Luc-TGFβ-M663-1,2 contains both sets of mutated nucleotides. The first 41 nucleotides of TGFβ1 3′-untranslated region is lacking in Luc- TGFβ-Del-663-1 . (B) Effects of pre-miR-663 on Luc- TGF β constructs. SW480 cells were transfected with wild type Luc- TGF β (WT) constructs both in sense and antisense orientation, with mutated Luc- TGF β constructs, (M663-1, M663-2, and M663-1,2), or with a Luc- TGF β construct bearing a deletion of the first 41 nt of TGFβ1 3′-UTR (Del-663-1), along with either a Control RNA (Pre-miR-Control) or pre-miR-663 . The sequences of the two mutated series of overlapping miR-663 target sites are given in panel A. Values represent the mean ± standard deviation (n = 4). *, Significantly different from Pre-miR-Control, P
    Figure Legend Snippet: MiR-663 targets TGFβ1 transcripts (A) Schematic representation (not to scale) of the 307 nt-long 3′-untranslated region of TGFβ1 transcripts. The positions of the two sets of overlapping miR-663 target sites (TS1 to TS5) are given in nucleotides. Their sequences (CCCCGCC) are given in black boxes. Nucleotides modified in the two single mutant constructs ( Luc- TGFβ-M663-1 and Luc- TGFβ-M663-2 ) are given below the figure (dashes correspond to conserved nucleotides). Luc-TGFβ-M663-1,2 contains both sets of mutated nucleotides. The first 41 nucleotides of TGFβ1 3′-untranslated region is lacking in Luc- TGFβ-Del-663-1 . (B) Effects of pre-miR-663 on Luc- TGF β constructs. SW480 cells were transfected with wild type Luc- TGF β (WT) constructs both in sense and antisense orientation, with mutated Luc- TGF β constructs, (M663-1, M663-2, and M663-1,2), or with a Luc- TGF β construct bearing a deletion of the first 41 nt of TGFβ1 3′-UTR (Del-663-1), along with either a Control RNA (Pre-miR-Control) or pre-miR-663 . The sequences of the two mutated series of overlapping miR-663 target sites are given in panel A. Values represent the mean ± standard deviation (n = 4). *, Significantly different from Pre-miR-Control, P

    Techniques Used: Modification, Mutagenesis, Construct, Transfection, Standard Deviation

    Resveratrol increases the levels of miR-663 as well as those of pri-miR-663 and pre-miR-663 differentially Total RNAs (0.6 μg) extracted from SW480 cells treated for 14 hours with either the vehicle (V) or resveratrol (R) were hybridized with a radiolabeled RNA antisense probe (P1, P2 or U6) in the presence of 4.4 μg of yeast tRNA. The schematic structure of the LO284801 locus, whose transcripts represent miR-663 primary transcripts, is presented on the unscaled top drawing. Open and filled boxes represent miR-663 precursor ( pre-miR-663 ) and mature miR-663 , respectively. P1 protects a 33 nt-long fragment starting 184 nt upstream of pre-miR-663. Pre-miR-663 and miR-663 respectively generate 40 and 22 nt-long protected fragments from P2, which corresponds to one of the miRNA micro-array probes. The relative intensity of the signal following resveratrol treatment is given between parentheses in percent of the vehicle sample, calculated using U6snRNA as an internal control. The efficiency of RNase digestion was assessed in parallel (two left lanes). Samples and controls were from the same gels. C-, no RNase (15 fold dilution); C+, RNase; Nd, non digested; Ns, non specific.
    Figure Legend Snippet: Resveratrol increases the levels of miR-663 as well as those of pri-miR-663 and pre-miR-663 differentially Total RNAs (0.6 μg) extracted from SW480 cells treated for 14 hours with either the vehicle (V) or resveratrol (R) were hybridized with a radiolabeled RNA antisense probe (P1, P2 or U6) in the presence of 4.4 μg of yeast tRNA. The schematic structure of the LO284801 locus, whose transcripts represent miR-663 primary transcripts, is presented on the unscaled top drawing. Open and filled boxes represent miR-663 precursor ( pre-miR-663 ) and mature miR-663 , respectively. P1 protects a 33 nt-long fragment starting 184 nt upstream of pre-miR-663. Pre-miR-663 and miR-663 respectively generate 40 and 22 nt-long protected fragments from P2, which corresponds to one of the miRNA micro-array probes. The relative intensity of the signal following resveratrol treatment is given between parentheses in percent of the vehicle sample, calculated using U6snRNA as an internal control. The efficiency of RNase digestion was assessed in parallel (two left lanes). Samples and controls were from the same gels. C-, no RNase (15 fold dilution); C+, RNase; Nd, non digested; Ns, non specific.

    Techniques Used: Microarray

    Resveratrol decreases the levels of TGFβ1 mainly in a miR-663 -independent manner SW480 cells were transfected with either a control RNA (pre-miR-Control), pre-miR-663 or an antisense miR-663 inhibitory RNA ( 663-I ) before resveratrol treatment. The levels of TGFβ1 and SMAD3 were then assessed on Western blots. The relative levels of TGFβ1and SMAD3 are given in percent of the corresponding Pre-miR-Control Vehicle-treated samples.
    Figure Legend Snippet: Resveratrol decreases the levels of TGFβ1 mainly in a miR-663 -independent manner SW480 cells were transfected with either a control RNA (pre-miR-Control), pre-miR-663 or an antisense miR-663 inhibitory RNA ( 663-I ) before resveratrol treatment. The levels of TGFβ1 and SMAD3 were then assessed on Western blots. The relative levels of TGFβ1and SMAD3 are given in percent of the corresponding Pre-miR-Control Vehicle-treated samples.

    Techniques Used: Transfection, Western Blot

    Resveratrol downregulates TGFβ1 transcripts through miR-663 SW480 cells were transfected with wild type (WT) or mutated (M663-1, M663-2, and M663-1,2) Luc- TGFβ constructs, along with either a Control RNA (Cont.) or a miR-663 antisense inhibitory RNA ( 663-I ) before resveratrol treatment. Bars show the ratios of the relative levels of expression of the different constructs to those of the empty pGL3-Control vector. Values represent the mean ± standard deviation (n = 4). * and **, Significantly different from the corresponding WT / Control, *, P = 0.05, **, P = 0.017 (df = 6).
    Figure Legend Snippet: Resveratrol downregulates TGFβ1 transcripts through miR-663 SW480 cells were transfected with wild type (WT) or mutated (M663-1, M663-2, and M663-1,2) Luc- TGFβ constructs, along with either a Control RNA (Cont.) or a miR-663 antisense inhibitory RNA ( 663-I ) before resveratrol treatment. Bars show the ratios of the relative levels of expression of the different constructs to those of the empty pGL3-Control vector. Values represent the mean ± standard deviation (n = 4). * and **, Significantly different from the corresponding WT / Control, *, P = 0.05, **, P = 0.017 (df = 6).

    Techniques Used: Transfection, Construct, Expressing, Plasmid Preparation, Standard Deviation

    Resveratrol decreases the expression of a SMAD2/SMAD3/SMAD4 luciferase reporter contruct After cotransfection with the SMAD2/SMAD3/SMAD4 luciferase reporter plasmid along with either a Control RNA (pre-miR-Control) or a miR-663 antisense inhibitory RNA ( 663-I ), SW480 cells were mock-treated or treated with TGFβ for 14 hours, and subsequently treated with the vehicle (Veh.) or resveratrol (Res.) for another 14 hours. The Firefly luciferase activity was measured 48 hours after transfection and then normalized to the Renilla luciferase activity. Values represent the mean ± standard deviation (n = 6). * and **, TGFβ1-treated significantly different from the corresponding Mock-treated, *, P
    Figure Legend Snippet: Resveratrol decreases the expression of a SMAD2/SMAD3/SMAD4 luciferase reporter contruct After cotransfection with the SMAD2/SMAD3/SMAD4 luciferase reporter plasmid along with either a Control RNA (pre-miR-Control) or a miR-663 antisense inhibitory RNA ( 663-I ), SW480 cells were mock-treated or treated with TGFβ for 14 hours, and subsequently treated with the vehicle (Veh.) or resveratrol (Res.) for another 14 hours. The Firefly luciferase activity was measured 48 hours after transfection and then normalized to the Renilla luciferase activity. Values represent the mean ± standard deviation (n = 6). * and **, TGFβ1-treated significantly different from the corresponding Mock-treated, *, P

    Techniques Used: Expressing, Luciferase, Cotransfection, Plasmid Preparation, Activity Assay, Transfection, Standard Deviation

    12) Product Images from "Evolutionary Conservation of Primate Lymphocryptovirus MicroRNA Targets"

    Article Title: Evolutionary Conservation of Primate Lymphocryptovirus MicroRNA Targets

    Journal: Journal of Virology

    doi: 10.1128/JVI.02071-13

    Deep sequencing analysis of lymphocryptovirus miRNAs. (A) Distribution of aligned, deep sequencing reads from RISC-immunoprecipitations (RIP-SEQ) or size-selected total RNA (smRNA). Reads from IBL-LCLd3 and Akata-LCLd3 (human LCLs infected with wild-type
    Figure Legend Snippet: Deep sequencing analysis of lymphocryptovirus miRNAs. (A) Distribution of aligned, deep sequencing reads from RISC-immunoprecipitations (RIP-SEQ) or size-selected total RNA (smRNA). Reads from IBL-LCLd3 and Akata-LCLd3 (human LCLs infected with wild-type

    Techniques Used: Sequencing, Infection

    13) Product Images from "Cooperating cancer-gene identification through oncogenic-retrovirus-induced insertional mutagenesis"

    Article Title: Cooperating cancer-gene identification through oncogenic-retrovirus-induced insertional mutagenesis

    Journal: Blood

    doi: 10.1182/blood-2004-12-4840

    Viral integrations decrease Sfpi1 expression and activate Mef2c expression. (A) Real-time RT-PCR analysis of total RNA isolated from spleens of leukemic animals in addition to spleen and bone marrow of normal mice using primers specific for mouse Sfpi1 . Relative gene expression levels were calculated by normalizing to β-actin mRNA levels in the same sample and in normal spleen. (B) Real-time RT-PCR analysis of the same samples using primers specific for mouse Mef2c .
    Figure Legend Snippet: Viral integrations decrease Sfpi1 expression and activate Mef2c expression. (A) Real-time RT-PCR analysis of total RNA isolated from spleens of leukemic animals in addition to spleen and bone marrow of normal mice using primers specific for mouse Sfpi1 . Relative gene expression levels were calculated by normalizing to β-actin mRNA levels in the same sample and in normal spleen. (B) Real-time RT-PCR analysis of the same samples using primers specific for mouse Mef2c .

    Techniques Used: Expressing, Quantitative RT-PCR, Isolation, Mouse Assay

    14) Product Images from ""

    Article Title:

    Journal: Drug Metabolism and Disposition

    doi: 10.1124/dmd.113.051904

    RNA Isolation, cDNA Synthesis, and Real-Time Polymerase Chain Reaction.
    Figure Legend Snippet: RNA Isolation, cDNA Synthesis, and Real-Time Polymerase Chain Reaction.

    Techniques Used: Isolation, Real-time Polymerase Chain Reaction

    15) Product Images from "Optimizing exosomal RNA isolation for RNA-Seq analyses of archival sera specimens"

    Article Title: Optimizing exosomal RNA isolation for RNA-Seq analyses of archival sera specimens

    Journal: PLoS ONE

    doi: 10.1371/journal.pone.0196913

    Exosomal RNA-Seq libraries from archival sera specimens. (A) Bioanalyzer results for 5 independent specimens demonstrate inserted size of exosomal RNAs. (B) Number of mapped reads generated from RNA-Seq libraries for 5 independent specimens with 20 ng exosomal RNAs. RNA-Seq library concentrations were calculated using three different methods: Nanodrop, BioAnalyzer (BioA), and RT-qPCR (qPCR). The Spearman’s rank correlations for Nanodrop versus reads, BioAnalyzer versus reads, and qPCR versus reads are 0.7 ( P = 0.23), 0.6 ( P = 0.35), and 0.7 ( P = 0.23), respectively. (C) Relative abundance of biotypes detected for 5 exosomal RNA-Seq libraries from healthy female subjects. PC = protein coding, PP = processed pseudogene, lincRNA = long intergenic non-coding RNA, UP = unprocessed pseudogene, snRNA = small nuclear RNA, miRNA = microRNA, TEC = to be experimentally confirmed, snoRNA = small nucleolar RNA, TUP = transcribed unprocessed pseudogene.
    Figure Legend Snippet: Exosomal RNA-Seq libraries from archival sera specimens. (A) Bioanalyzer results for 5 independent specimens demonstrate inserted size of exosomal RNAs. (B) Number of mapped reads generated from RNA-Seq libraries for 5 independent specimens with 20 ng exosomal RNAs. RNA-Seq library concentrations were calculated using three different methods: Nanodrop, BioAnalyzer (BioA), and RT-qPCR (qPCR). The Spearman’s rank correlations for Nanodrop versus reads, BioAnalyzer versus reads, and qPCR versus reads are 0.7 ( P = 0.23), 0.6 ( P = 0.35), and 0.7 ( P = 0.23), respectively. (C) Relative abundance of biotypes detected for 5 exosomal RNA-Seq libraries from healthy female subjects. PC = protein coding, PP = processed pseudogene, lincRNA = long intergenic non-coding RNA, UP = unprocessed pseudogene, snRNA = small nuclear RNA, miRNA = microRNA, TEC = to be experimentally confirmed, snoRNA = small nucleolar RNA, TUP = transcribed unprocessed pseudogene.

    Techniques Used: RNA Sequencing Assay, Generated, Quantitative RT-PCR, Real-time Polymerase Chain Reaction

    16) Product Images from "The Role of m6A/m-RNA Methylation in Stress Response Regulation"

    Article Title: The Role of m6A/m-RNA Methylation in Stress Response Regulation

    Journal: Neuron

    doi: 10.1016/j.neuron.2018.07.009

    Absolute Regulation of m 6 A/m Methylation Is Site Specific (A) A synthetic RNA oligonucleotide with three internal m 6 A/m sites was used for validation and internal normalization of the m 6 . (B) m 6 A/m-RIP-qPCR detects the methylated spike-in oligonucleotide in a linear fashion without impairing precipitation efficiency for endogenous transcripts in the concentration range used for experiments. Methylated spike-in oligo was added to unfragmented total RNA and precipitated with anti-m 6 A/m antibody (m 6 A/m-RIP) or rabbit IgG (IgG NC). n = 3 technical replicates, normalized expression to 1 fmol input control. Mean ± SEM. (C) m 6 A/m-RIP-qPCR accurately quantifies differential methylation of the spike-in oligo. Spike-in oligo (1 fmol) mixed from fully methylated and fully unmethylated spike-in was added to unfragmented total RNA and precipitated with m 6 A/m-RIP-qPCR. n = 3 technical replicates, normalized to input control. Mean ± SEM. (D) Absolute full-length m 6 . n = 8, mean ± SEM. Significant effects observed in FDR-corrected two-way MANOVA (p
    Figure Legend Snippet: Absolute Regulation of m 6 A/m Methylation Is Site Specific (A) A synthetic RNA oligonucleotide with three internal m 6 A/m sites was used for validation and internal normalization of the m 6 . (B) m 6 A/m-RIP-qPCR detects the methylated spike-in oligonucleotide in a linear fashion without impairing precipitation efficiency for endogenous transcripts in the concentration range used for experiments. Methylated spike-in oligo was added to unfragmented total RNA and precipitated with anti-m 6 A/m antibody (m 6 A/m-RIP) or rabbit IgG (IgG NC). n = 3 technical replicates, normalized expression to 1 fmol input control. Mean ± SEM. (C) m 6 A/m-RIP-qPCR accurately quantifies differential methylation of the spike-in oligo. Spike-in oligo (1 fmol) mixed from fully methylated and fully unmethylated spike-in was added to unfragmented total RNA and precipitated with m 6 A/m-RIP-qPCR. n = 3 technical replicates, normalized to input control. Mean ± SEM. (D) Absolute full-length m 6 . n = 8, mean ± SEM. Significant effects observed in FDR-corrected two-way MANOVA (p

    Techniques Used: Methylation, Real-time Polymerase Chain Reaction, Concentration Assay, Expressing

    17) Product Images from "miR-122, small RNA annealing and sequence mutations alter the predicted structure of the Hepatitis C virus 5′ UTR RNA to stabilize and promote viral RNA accumulation"

    Article Title: miR-122, small RNA annealing and sequence mutations alter the predicted structure of the Hepatitis C virus 5′ UTR RNA to stabilize and promote viral RNA accumulation

    Journal: Nucleic Acids Research

    doi: 10.1093/nar/gky662

    Wild-type HCV genomic RNA replication is promoted by 5′ UTR targeting siRNAs in Ago2 knockout Huh-7.5 cells. ( A and B ) Show the sequence and western blot data confirming the knockout of the Ago2 gene in two independent cell lines generated using CRISPR/Cas9 technology. Ago2 knockout Huh-7.5 cells line A4 were co-electroporated with wild-type or G33C HCV RNA and the indicated small RNAs and miR-122 antagonist (anti-122) or control antagonist (anti-124). ( C ) Time course transient replication assay of wild-type HCV RNA in Ago2 knockout Huh-7.5 cell lines. Time course transient replication assay of the impact of the siRNA on wild-type HCV RNA in wild-type Huh-7.5 cells ( D ) and Ago2 knockout Huh-7.5 cells ( E ). ( F ) Shows potent siRNA stimulation of transient replication of wild-type HCV RNA in Ago2 knockout Huh-7.5 cells when miR-122 activity is abolished by using a miR-122 antagonist and ( G ) shows potent stimulation of transient replication of G33C by si18-36 G33C in Ago2 knockout cells when miR-122 activity is abolished.
    Figure Legend Snippet: Wild-type HCV genomic RNA replication is promoted by 5′ UTR targeting siRNAs in Ago2 knockout Huh-7.5 cells. ( A and B ) Show the sequence and western blot data confirming the knockout of the Ago2 gene in two independent cell lines generated using CRISPR/Cas9 technology. Ago2 knockout Huh-7.5 cells line A4 were co-electroporated with wild-type or G33C HCV RNA and the indicated small RNAs and miR-122 antagonist (anti-122) or control antagonist (anti-124). ( C ) Time course transient replication assay of wild-type HCV RNA in Ago2 knockout Huh-7.5 cell lines. Time course transient replication assay of the impact of the siRNA on wild-type HCV RNA in wild-type Huh-7.5 cells ( D ) and Ago2 knockout Huh-7.5 cells ( E ). ( F ) Shows potent siRNA stimulation of transient replication of wild-type HCV RNA in Ago2 knockout Huh-7.5 cells when miR-122 activity is abolished by using a miR-122 antagonist and ( G ) shows potent stimulation of transient replication of G33C by si18-36 G33C in Ago2 knockout cells when miR-122 activity is abolished.

    Techniques Used: Knock-Out, Sequencing, Western Blot, Generated, CRISPR, Activity Assay

    Sequence and conservation of the 5′ terminal region of the HCV genome. ( A ) A schematic diagram of the HCV genome highlighting the 5′ terminal sequence, the miR-122 annealing sites and pattern of miR-122 annealing. ( B ) An RNA logo representation of the conservation of this sequence across five virus genotypes.
    Figure Legend Snippet: Sequence and conservation of the 5′ terminal region of the HCV genome. ( A ) A schematic diagram of the HCV genome highlighting the 5′ terminal sequence, the miR-122 annealing sites and pattern of miR-122 annealing. ( B ) An RNA logo representation of the conservation of this sequence across five virus genotypes.

    Techniques Used: Sequencing

    In silico RNA structure analysis of the 5′ UTR region of the HCV genome. RNA Structure prediction algorithms were used to predict the lowest free energy structures formed by the wild-type 5′ UTR sequence in the absence ( A ) or presence ( B ) of miR-122, and the complementary strand at the 3′ terminus ( C ).
    Figure Legend Snippet: In silico RNA structure analysis of the 5′ UTR region of the HCV genome. RNA Structure prediction algorithms were used to predict the lowest free energy structures formed by the wild-type 5′ UTR sequence in the absence ( A ) or presence ( B ) of miR-122, and the complementary strand at the 3′ terminus ( C ).

    Techniques Used: In Silico, RNA Structure Prediction, Sequencing

    Model for the mechanism of miR-122 promotion of HCV replication. ( A ) In the absence of miR-122 annealing the 5′ UTR forms a non-canonical RNA structure that does not support the HCV life cycle. ( B ) Annealing of miR-122 or a perfect match small RNA on or near the miR-122 binding sites, in conjunction with any Ago isoform modifies the 5′ UTR structure to form the canonical structure, protecting it from degradation by host phosphatases and exonucleases, and promoting the virus life cycle. Viral genomes having point mutations that favour the formation of the canonical RNA structure can replicate independently from miR-122 annealing, likely due to dynamic formation of both the canonical and non-canonical structures.
    Figure Legend Snippet: Model for the mechanism of miR-122 promotion of HCV replication. ( A ) In the absence of miR-122 annealing the 5′ UTR forms a non-canonical RNA structure that does not support the HCV life cycle. ( B ) Annealing of miR-122 or a perfect match small RNA on or near the miR-122 binding sites, in conjunction with any Ago isoform modifies the 5′ UTR structure to form the canonical structure, protecting it from degradation by host phosphatases and exonucleases, and promoting the virus life cycle. Viral genomes having point mutations that favour the formation of the canonical RNA structure can replicate independently from miR-122 annealing, likely due to dynamic formation of both the canonical and non-canonical structures.

    Techniques Used: Binding Assay

    Sequences of 5′UTR and transient replication assays of full length viral RNA having mutations to evolutionarily variable sites in siRNA target regions. ( A ) Sequence mutations are shown aligned with the canonical 5′ UTR in the presence of miR-122, and the complementary mutations in the structure of the negative strand 3′ terminus. ( B ) Transient HCV replication assay analysis of the mutant virus RNA in wild-type Huh-7.5 cells. Luciferase expression was measured as a proxy for genome amplification in cells transfected with full length HCV genomic RNA carrying a luciferase reporter gene and the indicated mutation. Data are the average of three independent transfections and error bars represent the standard deviation. The differences in replication fitness of the mutant viruses versus wild-type (miControl) at each time point was analyzed by one-way ANOVA and P -values are indicated as follows * 0.05 to 0.005, ** 0.005 to 0.0001 and ***
    Figure Legend Snippet: Sequences of 5′UTR and transient replication assays of full length viral RNA having mutations to evolutionarily variable sites in siRNA target regions. ( A ) Sequence mutations are shown aligned with the canonical 5′ UTR in the presence of miR-122, and the complementary mutations in the structure of the negative strand 3′ terminus. ( B ) Transient HCV replication assay analysis of the mutant virus RNA in wild-type Huh-7.5 cells. Luciferase expression was measured as a proxy for genome amplification in cells transfected with full length HCV genomic RNA carrying a luciferase reporter gene and the indicated mutation. Data are the average of three independent transfections and error bars represent the standard deviation. The differences in replication fitness of the mutant viruses versus wild-type (miControl) at each time point was analyzed by one-way ANOVA and P -values are indicated as follows * 0.05 to 0.005, ** 0.005 to 0.0001 and ***

    Techniques Used: Sequencing, Mutagenesis, Luciferase, Expressing, Amplification, Transfection, Standard Deviation

    The RNA construct, knockdown efficiency and mutants isolated during the siRNA-directed mutagenesis method. Cells harboring the HCV bicistronic full length replicon RNA shown in ( A ) were repeatedly electroporated with si18-36, si19-37 or si6367, and selected with G418 to pressure the selection of siRNA escape mutants. ( B – D ) Luciferase expression was assessed 3 days after siRNA electroporation for each iteration of the selection process to detect the evolution of knockdown resistance (left panel). Following seven rounds of knockdown and selection, the 5′ UTR sequence was amplified, cloned and sequenced. The sequence and incidence of mutations within the 5′ targeted site is shown for each siRNA used (right panel).
    Figure Legend Snippet: The RNA construct, knockdown efficiency and mutants isolated during the siRNA-directed mutagenesis method. Cells harboring the HCV bicistronic full length replicon RNA shown in ( A ) were repeatedly electroporated with si18-36, si19-37 or si6367, and selected with G418 to pressure the selection of siRNA escape mutants. ( B – D ) Luciferase expression was assessed 3 days after siRNA electroporation for each iteration of the selection process to detect the evolution of knockdown resistance (left panel). Following seven rounds of knockdown and selection, the 5′ UTR sequence was amplified, cloned and sequenced. The sequence and incidence of mutations within the 5′ targeted site is shown for each siRNA used (right panel).

    Techniques Used: Construct, Isolation, Mutagenesis, Selection, Luciferase, Expressing, Electroporation, Sequencing, Amplification, Clone Assay

    Sequence and replication analysis of viruses whose replication was promoted by the siRNA used in the mutation selection method. Viruses selected by si18-36 or si19-37 were tested for promotion by their respective selection siRNA. ( A ) Viruses whose replication was promoted by si18-36 and si19-37 when miR-122 was absent. The indicated viral RNAs were co-transfected with either si18-36, si19-37 or siControl into miR-122-knockout Huh-7.5 cells and replication was assessed based on luciferase expression. ( B ) The 5′ UTR sequences of viruses whose replication was promoted by si18-36 or si19-37, and the specific annealing between si18-36 and C26U are shown. ( C – E ) Time course analysis in wild-type and miR-122-knockout cells of C26U with various small RNAs. C26U RNA was co-electroporated into (C and E) wild-type or (D) miR-122-knockout Huh-7.5 cells with the indicated miRNA, siRNA or miR-122 antagonist (anti122). ( F ) Time course analysis of WT HCV RNA in miR-122-knockout cells with the indicated small RNAs.
    Figure Legend Snippet: Sequence and replication analysis of viruses whose replication was promoted by the siRNA used in the mutation selection method. Viruses selected by si18-36 or si19-37 were tested for promotion by their respective selection siRNA. ( A ) Viruses whose replication was promoted by si18-36 and si19-37 when miR-122 was absent. The indicated viral RNAs were co-transfected with either si18-36, si19-37 or siControl into miR-122-knockout Huh-7.5 cells and replication was assessed based on luciferase expression. ( B ) The 5′ UTR sequences of viruses whose replication was promoted by si18-36 or si19-37, and the specific annealing between si18-36 and C26U are shown. ( C – E ) Time course analysis in wild-type and miR-122-knockout cells of C26U with various small RNAs. C26U RNA was co-electroporated into (C and E) wild-type or (D) miR-122-knockout Huh-7.5 cells with the indicated miRNA, siRNA or miR-122 antagonist (anti122). ( F ) Time course analysis of WT HCV RNA in miR-122-knockout cells with the indicated small RNAs.

    Techniques Used: Sequencing, Mutagenesis, Selection, Transfection, Knock-Out, Luciferase, Expressing

    Sequence and transient replication assays of full length viral RNA having mutations to evolutionarily conserved sites in siRNA target regions. ( A ) Sequence mutations are shown aligned with the canonical 5′ UTR in the presence of miR-122, and the complementary mutations in the structure of the 3′ terminus. ( B ) Transient HCV replication assay analysis of mutant full length viral RNA in wild-type Huh-7.5 cells. Luciferase expression measured 2 days post-transfection was used as a proxy to assess viral genomic RNA amplification in cells transfected with full length HCV genomic RNAs harboring a luciferase reporter gene and the indicated mutation. Data are the average of three independent transfections and error bars represent the standard deviation. The relative replication fitness of the mutant viruses versus wild-type (siControl) was analyzed by one-way ANOVA and P -values are indicated as follows * 0.05 to 0.005, ** 0.005 to 0.0001 and ***
    Figure Legend Snippet: Sequence and transient replication assays of full length viral RNA having mutations to evolutionarily conserved sites in siRNA target regions. ( A ) Sequence mutations are shown aligned with the canonical 5′ UTR in the presence of miR-122, and the complementary mutations in the structure of the 3′ terminus. ( B ) Transient HCV replication assay analysis of mutant full length viral RNA in wild-type Huh-7.5 cells. Luciferase expression measured 2 days post-transfection was used as a proxy to assess viral genomic RNA amplification in cells transfected with full length HCV genomic RNAs harboring a luciferase reporter gene and the indicated mutation. Data are the average of three independent transfections and error bars represent the standard deviation. The relative replication fitness of the mutant viruses versus wild-type (siControl) was analyzed by one-way ANOVA and P -values are indicated as follows * 0.05 to 0.005, ** 0.005 to 0.0001 and ***

    Techniques Used: Sequencing, Mutagenesis, Luciferase, Expressing, Transfection, Amplification, Standard Deviation

    si19-37 annealing stabilizes HCV genomic RNA in Ago2 knockout cells. Ago2 cells were elecroporated with non-replicative HCV RNA and the indicated siRNAs and miRNA antagonists, anti-122 or the control anti-124. RNA was prepared from the cells at the indicated short term time points post-electroporation and probed for HCV and Actin RNA to evaluate HCV RNA stability. A representative northern blot analysis of an HCV RNA stability assay is shown in ( A ) and the quantification of three independent assays is shown in ( B ).
    Figure Legend Snippet: si19-37 annealing stabilizes HCV genomic RNA in Ago2 knockout cells. Ago2 cells were elecroporated with non-replicative HCV RNA and the indicated siRNAs and miRNA antagonists, anti-122 or the control anti-124. RNA was prepared from the cells at the indicated short term time points post-electroporation and probed for HCV and Actin RNA to evaluate HCV RNA stability. A representative northern blot analysis of an HCV RNA stability assay is shown in ( A ) and the quantification of three independent assays is shown in ( B ).

    Techniques Used: Knock-Out, Electroporation, Northern Blot, Stability Assay

    18) Product Images from "Non-homologous recombination between Alu and LINE-1 repeats results in a 91 kb deletion in MERTK causing severe retinitis pigmentosa"

    Article Title: Non-homologous recombination between Alu and LINE-1 repeats results in a 91 kb deletion in MERTK causing severe retinitis pigmentosa

    Journal: Molecular Vision

    doi:

    MERTK c.-8162_1145–1212del, p.? and c.2309A > G, p.Glu770Gly are allelic variants. A : Localization of MERTK -specific primers. B : Reverse transcription PCR (RT–PCR) was performed on cDNA derived from RP116 and control RNA. Using primers 7F and 18R, we could amplify only an allele without a deletion covering exon 7 (1292 bp). PCR with 15F and 18R was used as control (372 bp). Primers sequences and PCR conditions are described in Materials and Methods and Results. C : Sanger sequencing reveals the presence of the heterozygous c.2309A > G mutation in DNA of RP116 (upper panel), the presence of the mutation c.2309G in RNA of RP116 (middle panel), and the presence of a reference A in the control RNA (lower panel).
    Figure Legend Snippet: MERTK c.-8162_1145–1212del, p.? and c.2309A > G, p.Glu770Gly are allelic variants. A : Localization of MERTK -specific primers. B : Reverse transcription PCR (RT–PCR) was performed on cDNA derived from RP116 and control RNA. Using primers 7F and 18R, we could amplify only an allele without a deletion covering exon 7 (1292 bp). PCR with 15F and 18R was used as control (372 bp). Primers sequences and PCR conditions are described in Materials and Methods and Results. C : Sanger sequencing reveals the presence of the heterozygous c.2309A > G mutation in DNA of RP116 (upper panel), the presence of the mutation c.2309G in RNA of RP116 (middle panel), and the presence of a reference A in the control RNA (lower panel).

    Techniques Used: Polymerase Chain Reaction, Reverse Transcription Polymerase Chain Reaction, Derivative Assay, Sequencing, Mutagenesis

    19) Product Images from "Human papillomavirus E7 induces p63 expression to modulate DNA damage response"

    Article Title: Human papillomavirus E7 induces p63 expression to modulate DNA damage response

    Journal: Cell Death & Disease

    doi: 10.1038/s41419-017-0149-6

    E7 promotes p63 expression at transcriptional level a CaSki cells were transfected with scrambled siRNA or E7-siRNA. Forty-eight hours later, cells were treated with the proteasome inhibitor MG132 (20 μM). The untreated control cells and MG132-treated cells were harvested 4 h later and expression of E7 and p63 were assessed by western blotting. The intensity of the bands was quantified by using the ImageJ software. b Q-PCR was used to quantitate E7 and p63 transcript levels in E7-depleted cells 48 h following transfection. c and d Total RNA from C33A, SiHa, and CaSki cells was extracted and reversed by using random primers. The cDNA was used to analyse the transcript levels of E7 ( c ) and p63 ( d ) by Q-PCR
    Figure Legend Snippet: E7 promotes p63 expression at transcriptional level a CaSki cells were transfected with scrambled siRNA or E7-siRNA. Forty-eight hours later, cells were treated with the proteasome inhibitor MG132 (20 μM). The untreated control cells and MG132-treated cells were harvested 4 h later and expression of E7 and p63 were assessed by western blotting. The intensity of the bands was quantified by using the ImageJ software. b Q-PCR was used to quantitate E7 and p63 transcript levels in E7-depleted cells 48 h following transfection. c and d Total RNA from C33A, SiHa, and CaSki cells was extracted and reversed by using random primers. The cDNA was used to analyse the transcript levels of E7 ( c ) and p63 ( d ) by Q-PCR

    Techniques Used: Expressing, Transfection, Western Blot, Software, Polymerase Chain Reaction

    20) Product Images from "Purification of Highly Active Alphavirus Replication Complexes Demonstrates Altered Fractionation of Multiple Cellular Membranes"

    Article Title: Purification of Highly Active Alphavirus Replication Complexes Demonstrates Altered Fractionation of Multiple Cellular Membranes

    Journal: Journal of Virology

    doi: 10.1128/JVI.01852-17

    Characterization of the in vitro replication activity of the purified RCs. (A) Stability of newly synthesized SFV genomic RNA. After a 60-min replication assay, [ 32 P]CTP incorporation was blocked by the addition of 100 μM 3′-dCTP, and incubation at 30°C was continued for an additional 180 min. The graph on the left represents an assay with 10-fold-diluted S7 and on the right with the purified RCs. At the indicated chase times radioactivity in 42S was quantified (yellow). As a control, a reaction without 3′-dCTP was quantified (blue). In addition, in vitro transcript of Tmed added in the reaction at a 0-min chase was quantified by in-gel hybridization (green). All values are presented as percentages of the values at the 0-min chase. (B) Purified RCs and additional exogenous template. Replication assay reaction mixtures were incubated for 2 h. RCs indicates [ 32 P]CTP incorporation by the purified RCs. RCs + Tmed RNA shows incorporation by the purified RCs after an exogenous Tmed RNA transcript was added. As a control, [ 32 P]CTP incorporation by the P15 membrane fraction from cells transfected with the P1234 polyprotein and Tmed template plasmids is shown, and genomic and subgenomic (SG) Tmed are indicated. The lower panel shows the presence of Tmed, detected by in-gel hybridization. (C) Detergent stability and sensitivity. Purified RCs were treated with 1% Tx-100, followed by an assay to detect replication (upper) and in-gel hybridization to detect the minus-strand template RNA (lower). (D) ssRNA and RF/RI forms of in vitro -synthesized RNAs. After a 2-h replication assay with the purified RCs, RNA was isolated and treated with RNase A/T1 or III under high-salt conditions to specifically digest ssRNA or dsRNA, respectively, and analyzed under denaturing (left) or nondenaturing (right) conditions. (E) Release of newly made RNA. A replication assay was performed with the concentrated purified RCs, and after 60-, 120-, and 180-min replication reactions, aliquots were removed to prepare pellet and supernatant fractions, followed by RNA isolation and analysis in a denaturing agarose gel. The schematic shows how [ 32 P]CTP is incorporated into viral RNA during in vitro RNA synthesis, resulting in dsRNA containing a plus strand synthesized both in cells (indicated by magenta) and in vitro (indicated by orange). After a round of replication and release of the previous plus strand, an RC contains only the in vitro -synthesized plus strand if replication is semiconservative. (F) Increase in the amount of RNA during in vitro replication. After a 4-h replication assay with the purified RCs and unlabeled NTPs, RNA was isolated and genomic RNA was detected by in-gel hybridization. No NTPs indicates a reaction without added NTPs, and ctrl indicates a sample without any incubations before RNA isolation. 42S RNA was quantified, and average percentages from two independent experiments are shown in the table.
    Figure Legend Snippet: Characterization of the in vitro replication activity of the purified RCs. (A) Stability of newly synthesized SFV genomic RNA. After a 60-min replication assay, [ 32 P]CTP incorporation was blocked by the addition of 100 μM 3′-dCTP, and incubation at 30°C was continued for an additional 180 min. The graph on the left represents an assay with 10-fold-diluted S7 and on the right with the purified RCs. At the indicated chase times radioactivity in 42S was quantified (yellow). As a control, a reaction without 3′-dCTP was quantified (blue). In addition, in vitro transcript of Tmed added in the reaction at a 0-min chase was quantified by in-gel hybridization (green). All values are presented as percentages of the values at the 0-min chase. (B) Purified RCs and additional exogenous template. Replication assay reaction mixtures were incubated for 2 h. RCs indicates [ 32 P]CTP incorporation by the purified RCs. RCs + Tmed RNA shows incorporation by the purified RCs after an exogenous Tmed RNA transcript was added. As a control, [ 32 P]CTP incorporation by the P15 membrane fraction from cells transfected with the P1234 polyprotein and Tmed template plasmids is shown, and genomic and subgenomic (SG) Tmed are indicated. The lower panel shows the presence of Tmed, detected by in-gel hybridization. (C) Detergent stability and sensitivity. Purified RCs were treated with 1% Tx-100, followed by an assay to detect replication (upper) and in-gel hybridization to detect the minus-strand template RNA (lower). (D) ssRNA and RF/RI forms of in vitro -synthesized RNAs. After a 2-h replication assay with the purified RCs, RNA was isolated and treated with RNase A/T1 or III under high-salt conditions to specifically digest ssRNA or dsRNA, respectively, and analyzed under denaturing (left) or nondenaturing (right) conditions. (E) Release of newly made RNA. A replication assay was performed with the concentrated purified RCs, and after 60-, 120-, and 180-min replication reactions, aliquots were removed to prepare pellet and supernatant fractions, followed by RNA isolation and analysis in a denaturing agarose gel. The schematic shows how [ 32 P]CTP is incorporated into viral RNA during in vitro RNA synthesis, resulting in dsRNA containing a plus strand synthesized both in cells (indicated by magenta) and in vitro (indicated by orange). After a round of replication and release of the previous plus strand, an RC contains only the in vitro -synthesized plus strand if replication is semiconservative. (F) Increase in the amount of RNA during in vitro replication. After a 4-h replication assay with the purified RCs and unlabeled NTPs, RNA was isolated and genomic RNA was detected by in-gel hybridization. No NTPs indicates a reaction without added NTPs, and ctrl indicates a sample without any incubations before RNA isolation. 42S RNA was quantified, and average percentages from two independent experiments are shown in the table.

    Techniques Used: In Vitro, Activity Assay, Purification, Synthesized, Incubation, Radioactivity, Hybridization, Transfection, Isolation, Agarose Gel Electrophoresis

    21) Product Images from "Type 1 IFN-independent activation of a subset of interferon stimulated genes in West Nile virus Eg101-infected mouse cells"

    Article Title: Type 1 IFN-independent activation of a subset of interferon stimulated genes in West Nile virus Eg101-infected mouse cells

    Journal: Virology

    doi: 10.1016/j.virol.2012.01.006

    IFN beta is produced by WNV Eg101 infected MEFs and induces phosphorylation of STAT1 and STAT2 MEFs were mock-infected or infected with WNV Eg101 at a MOI of 5 for the indicated times or treated with 1000 U/ml of murine IFN beta for 3h. (A) Total RNA from tC3H/He MEFs was extracted and IFN beta mRNA levels were measured by real-time qRT-PCR. (B) Extracellular IFN beta protein levels in tC3H/He MEF culture fluid was measured by ELISA. The values shown are averages from at least two independent experiments performed in triplicate. The error bars represent SDM. (C) tC3H/He cell lysates were analyzed by Western blotting using antibodies specific for the indicated proteins. Actin was used as the loading control. The blots shown are representative of results obtained from three independent experiments. (D) and (E) Comparison of ISG activation by IFN beta in primary and transformed MEFs. Total RNA was extracted from (D) tC3H/He or (E) pC3H/He MEFs infected with WNV Eg101 (MOI 5) for the indicated times, mock-infected or treated with murine IFN beta (1000 U/ml) for 3h. The changes in the levels of Oas1a and Oas1b mRNA were assessed by real-time qRT-PCR. Each experiment was repeated at least two times in triplicate. The mRNA level of each gene was normalized to the level of GAPDH mRNA in that sample and is shown as the fold change over the amount of mRNA in mock samples expressed in relative quantification units (RQU). The error bars represent the calculated SEM (n = 3) and are based on an RQ Min/Max of the 95% confidence level.
    Figure Legend Snippet: IFN beta is produced by WNV Eg101 infected MEFs and induces phosphorylation of STAT1 and STAT2 MEFs were mock-infected or infected with WNV Eg101 at a MOI of 5 for the indicated times or treated with 1000 U/ml of murine IFN beta for 3h. (A) Total RNA from tC3H/He MEFs was extracted and IFN beta mRNA levels were measured by real-time qRT-PCR. (B) Extracellular IFN beta protein levels in tC3H/He MEF culture fluid was measured by ELISA. The values shown are averages from at least two independent experiments performed in triplicate. The error bars represent SDM. (C) tC3H/He cell lysates were analyzed by Western blotting using antibodies specific for the indicated proteins. Actin was used as the loading control. The blots shown are representative of results obtained from three independent experiments. (D) and (E) Comparison of ISG activation by IFN beta in primary and transformed MEFs. Total RNA was extracted from (D) tC3H/He or (E) pC3H/He MEFs infected with WNV Eg101 (MOI 5) for the indicated times, mock-infected or treated with murine IFN beta (1000 U/ml) for 3h. The changes in the levels of Oas1a and Oas1b mRNA were assessed by real-time qRT-PCR. Each experiment was repeated at least two times in triplicate. The mRNA level of each gene was normalized to the level of GAPDH mRNA in that sample and is shown as the fold change over the amount of mRNA in mock samples expressed in relative quantification units (RQU). The error bars represent the calculated SEM (n = 3) and are based on an RQ Min/Max of the 95% confidence level.

    Techniques Used: Produced, Infection, Quantitative RT-PCR, Enzyme-linked Immunosorbent Assay, Western Blot, Activation Assay, Transformation Assay

    22) Product Images from "Identification and validation of microRNAs directly regulating the UDP-glucuronosyltransferase 1A subfamily enzymes by a functional genomics approach"

    Article Title: Identification and validation of microRNAs directly regulating the UDP-glucuronosyltransferase 1A subfamily enzymes by a functional genomics approach

    Journal: Biochemical pharmacology

    doi: 10.1016/j.bcp.2017.04.017

    Effect of miRNA mimic overexpression on UGT1A1 (A), UGT1A6 (B), and UGT2B7 (C) selective activities and mRNA levels in LS180 human intestinal cells. miRNA mimics or the mimic negative controls were transfected into LS180 cells at 30 nM concentration. 48 hr after transfection, glucuronidation activities (UGT1A1: ezetimibe glucuronidation, Ez-Glu; UGT1A6: 5-hydroxytryptamine glucuronidation, 5HT-Glu; UGT2B7: morphine 3-glucuronidation, M3-Glu) were measured and total RNA isolated for the measurement of expression levels of the respective genes. Glucuronidation activity values and mRNA levels were compared with the average values of cells transfected with the mimic negative controls and non-transfected cells (control). Bars represent mean ± one S.D. from three independent experiments performed in quadruplicate. * p
    Figure Legend Snippet: Effect of miRNA mimic overexpression on UGT1A1 (A), UGT1A6 (B), and UGT2B7 (C) selective activities and mRNA levels in LS180 human intestinal cells. miRNA mimics or the mimic negative controls were transfected into LS180 cells at 30 nM concentration. 48 hr after transfection, glucuronidation activities (UGT1A1: ezetimibe glucuronidation, Ez-Glu; UGT1A6: 5-hydroxytryptamine glucuronidation, 5HT-Glu; UGT2B7: morphine 3-glucuronidation, M3-Glu) were measured and total RNA isolated for the measurement of expression levels of the respective genes. Glucuronidation activity values and mRNA levels were compared with the average values of cells transfected with the mimic negative controls and non-transfected cells (control). Bars represent mean ± one S.D. from three independent experiments performed in quadruplicate. * p

    Techniques Used: Over Expression, Transfection, Concentration Assay, Isolation, Expressing, Activity Assay

    23) Product Images from "Identification of PARP-7 substrates reveals a role for MARylation in microtubule control in ovarian cancer cells"

    Article Title: Identification of PARP-7 substrates reveals a role for MARylation in microtubule control in ovarian cancer cells

    Journal: eLife

    doi: 10.7554/eLife.60481

    RNA-seq analysis of gene expression in ovarian cancer cells following PARP-7 depletion. ( A ) Western blots showing PARP-7 protein levels after siRNA-mediated knockdown (KD) of PARP7 in OVCAR4 cells. Three different siRNAs were used. β-tubulin was used as loading control. ( B ) Heat maps showing the results of RNA-seq assays from OVCAR4 cells upon siRNA-mediated knockdown (KD) of PARP7. Three different siRNAs were used. Results represent fold changes in FPKM values for genes significantly regulated versus the control KD, expressed as log 2 fold change. A fold change ≥1.5 was classified as upregulated, while a fold change ≤−0.5 was classified as downregulated. ( C ) Gene ontology terms enriched for the significantly upregulated genes ( yellow ) and significantly downregulated genes ( blue ) shown in ( B ). The percent of targets from each GO term identified in the analysis is shown, along with the log 10 p-value for the enrichment.
    Figure Legend Snippet: RNA-seq analysis of gene expression in ovarian cancer cells following PARP-7 depletion. ( A ) Western blots showing PARP-7 protein levels after siRNA-mediated knockdown (KD) of PARP7 in OVCAR4 cells. Three different siRNAs were used. β-tubulin was used as loading control. ( B ) Heat maps showing the results of RNA-seq assays from OVCAR4 cells upon siRNA-mediated knockdown (KD) of PARP7. Three different siRNAs were used. Results represent fold changes in FPKM values for genes significantly regulated versus the control KD, expressed as log 2 fold change. A fold change ≥1.5 was classified as upregulated, while a fold change ≤−0.5 was classified as downregulated. ( C ) Gene ontology terms enriched for the significantly upregulated genes ( yellow ) and significantly downregulated genes ( blue ) shown in ( B ). The percent of targets from each GO term identified in the analysis is shown, along with the log 10 p-value for the enrichment.

    Techniques Used: RNA Sequencing Assay, Expressing, Western Blot

    24) Product Images from "SIV replication is directly downregulated by four antiviral miRNAs"

    Article Title: SIV replication is directly downregulated by four antiviral miRNAs

    Journal: Retrovirology

    doi: 10.1186/1742-4690-10-95

    SIV infection increases levels of mature miR- 29a (A), -29b (B), -9 (C) and -146a (D). Macaque macrophages were infected with SIV (MOI 0.05). Cells were harvested at 2, 4, 8, 12, 24 and 48 hours after infection and RNA was isolated. Taqman miRNA RT-qPCR assays were used to measure levels of mature miRNAs. Results were normalized to U6, then to uninfected samples for the individual time points (ΔΔCq method). Values are expressed as fold induction of miRNAs over uninfected controls using the ΔΔCq method and data shown is an average of at least 3 experiments.
    Figure Legend Snippet: SIV infection increases levels of mature miR- 29a (A), -29b (B), -9 (C) and -146a (D). Macaque macrophages were infected with SIV (MOI 0.05). Cells were harvested at 2, 4, 8, 12, 24 and 48 hours after infection and RNA was isolated. Taqman miRNA RT-qPCR assays were used to measure levels of mature miRNAs. Results were normalized to U6, then to uninfected samples for the individual time points (ΔΔCq method). Values are expressed as fold induction of miRNAs over uninfected controls using the ΔΔCq method and data shown is an average of at least 3 experiments.

    Techniques Used: Infection, Isolation, miRNA RT, Real-time Polymerase Chain Reaction

    TNFα increases levels of mature miRNAs and primary miRNA transcripts in human macrophages. Human macrophages were treated with 20 ng/ml TNFα. Cells were harvested at 2, 4, 8, 12 and 24 hours after treatment and RNA isolated. (A-D) Taqman miRNA RT-qPCR assays were used to measure levels of mature miRNAs. (E-H) Taqman pri-miRNA RT-qPCR assays were used to measure levels of primary miRNA transcripts. Results were normalized to U6. Values are expressed as fold induction of miRNAs over uninfected controls using the ΔΔCq method and data shown is an average of at least 3 experiments.
    Figure Legend Snippet: TNFα increases levels of mature miRNAs and primary miRNA transcripts in human macrophages. Human macrophages were treated with 20 ng/ml TNFα. Cells were harvested at 2, 4, 8, 12 and 24 hours after treatment and RNA isolated. (A-D) Taqman miRNA RT-qPCR assays were used to measure levels of mature miRNAs. (E-H) Taqman pri-miRNA RT-qPCR assays were used to measure levels of primary miRNA transcripts. Results were normalized to U6. Values are expressed as fold induction of miRNAs over uninfected controls using the ΔΔCq method and data shown is an average of at least 3 experiments.

    Techniques Used: Isolation, miRNA RT, Real-time Polymerase Chain Reaction

    Four miRNAs reduce levels of full length and multiply spliced viral RNAs. Primary macaque macrophages were transfected with 100 nM of either miRNA mimics or antagonists, then infected with SIV (MOI 0.05) 24 hours after transfection. Cell lysates were collected at 24, 48 and 72 hours post-infection for miRNA experiments and 48 hours for miRNA antagonist experiments. Levels of full length (A, C) and spliced (B) RNA was measured by RT-qPCR. Values are expressed as fold change over SIV-only controls. Results are reported as percent of SIV-only control using the ΔΔCq method.
    Figure Legend Snippet: Four miRNAs reduce levels of full length and multiply spliced viral RNAs. Primary macaque macrophages were transfected with 100 nM of either miRNA mimics or antagonists, then infected with SIV (MOI 0.05) 24 hours after transfection. Cell lysates were collected at 24, 48 and 72 hours post-infection for miRNA experiments and 48 hours for miRNA antagonist experiments. Levels of full length (A, C) and spliced (B) RNA was measured by RT-qPCR. Values are expressed as fold change over SIV-only controls. Results are reported as percent of SIV-only control using the ΔΔCq method.

    Techniques Used: Transfection, Infection, Quantitative RT-PCR

    miRs-29a, -29b, -9 and -146a reduce expression of a luciferase reporter and target predicted binding sites in the 3′ UTR of SIV. (A) SIV nef / U3 - R was cloned into psiCHECK2 plasmid (Promega). 293T cells were co-transfection with 50 nM or 100 nM of each miRNA or scrambled mimic and 100 ng of either psiCHECK+SIV or psiCHECK alone. Control samples were transfected with either psiCHECK or psiCHECK+SIV, and no miRNA mimics. Cells were harvested 24 hours after transfection. Data shown is an average of four experiments and represents miRNA effect on luciferase expression for psiCHECK+SIV over psiCHECK only. (B) WT and mutant biotin-labeled oligos corresponding to SIV RNA sequences containing predicted miRNA binding sites. WT oligo is show on top and mutant on bottom. Boxed bases on WT oligo denote miRNA seed binding site in SIV sequence. Mutant oligo highlighted bases denote the change in seed-binding region. Annotation is based on SIV sequence AY033146. (C) 100 pmol of individual WT or mt oligos were transfected into HeLa cells and lysates collected 24 hours after transfection. Oligos were pulled down using Streptavidin beads and assayed for binding to endogenous cellular miRNAs using Taqman RT-qPCR. Percent input was calculated for each sample (see methods) and data presented as (% input mt )/(% input WT) with % of input of WT set to 100%. In each experiment, the value of the oligo which pulled down the highest percentage of individual endogenous miRNA was set to 100% and binding by other oligos was compared to this value. Data shown is an average of 4 experiments. Statistics represent the comparison of percent of miRNA bound to WT oligo compared to percent of miRNA pulled down by corresponding mt oligo and are reported as a two-tailed t test assuming unequal variance.
    Figure Legend Snippet: miRs-29a, -29b, -9 and -146a reduce expression of a luciferase reporter and target predicted binding sites in the 3′ UTR of SIV. (A) SIV nef / U3 - R was cloned into psiCHECK2 plasmid (Promega). 293T cells were co-transfection with 50 nM or 100 nM of each miRNA or scrambled mimic and 100 ng of either psiCHECK+SIV or psiCHECK alone. Control samples were transfected with either psiCHECK or psiCHECK+SIV, and no miRNA mimics. Cells were harvested 24 hours after transfection. Data shown is an average of four experiments and represents miRNA effect on luciferase expression for psiCHECK+SIV over psiCHECK only. (B) WT and mutant biotin-labeled oligos corresponding to SIV RNA sequences containing predicted miRNA binding sites. WT oligo is show on top and mutant on bottom. Boxed bases on WT oligo denote miRNA seed binding site in SIV sequence. Mutant oligo highlighted bases denote the change in seed-binding region. Annotation is based on SIV sequence AY033146. (C) 100 pmol of individual WT or mt oligos were transfected into HeLa cells and lysates collected 24 hours after transfection. Oligos were pulled down using Streptavidin beads and assayed for binding to endogenous cellular miRNAs using Taqman RT-qPCR. Percent input was calculated for each sample (see methods) and data presented as (% input mt )/(% input WT) with % of input of WT set to 100%. In each experiment, the value of the oligo which pulled down the highest percentage of individual endogenous miRNA was set to 100% and binding by other oligos was compared to this value. Data shown is an average of 4 experiments. Statistics represent the comparison of percent of miRNA bound to WT oligo compared to percent of miRNA pulled down by corresponding mt oligo and are reported as a two-tailed t test assuming unequal variance.

    Techniques Used: Expressing, Luciferase, Binding Assay, Clone Assay, Plasmid Preparation, Cotransfection, Transfection, Mutagenesis, Labeling, Sequencing, Quantitative RT-PCR, Two Tailed Test

    IFNβ increases levels of mature miRNAs and primary miRNA transcripts in human macrophages. Human macrophages were treated with 100 U/ml IFNβ and cells were harvested at 4, 8, 12 and 24 hours after treatment and RNA isolated. (A-D) Taqman miRNA RT-qPCR assays were used to measure levels of mature miRNAs. (E-H) Taqman pri-miRNA RT-qPCR assays were used to measure levels of primary miRNA transcripts. Results were normalized to U6. Values are expressed as fold induction of miRNAs over uninfected controls using the ΔΔCq method and data shown is an average of at least 3 experiments.
    Figure Legend Snippet: IFNβ increases levels of mature miRNAs and primary miRNA transcripts in human macrophages. Human macrophages were treated with 100 U/ml IFNβ and cells were harvested at 4, 8, 12 and 24 hours after treatment and RNA isolated. (A-D) Taqman miRNA RT-qPCR assays were used to measure levels of mature miRNAs. (E-H) Taqman pri-miRNA RT-qPCR assays were used to measure levels of primary miRNA transcripts. Results were normalized to U6. Values are expressed as fold induction of miRNAs over uninfected controls using the ΔΔCq method and data shown is an average of at least 3 experiments.

    Techniques Used: Isolation, miRNA RT, Real-time Polymerase Chain Reaction

    25) Product Images from "Identification and characterization of two novel alternatively spliced E2F1 transcripts in the rat CNS"

    Article Title: Identification and characterization of two novel alternatively spliced E2F1 transcripts in the rat CNS

    Journal: Molecular and cellular neurosciences

    doi: 10.1016/j.mcn.2018.06.003

    Detection of E2F1 variants in tissue A. PCR amplification of E2F1 variants in indicated tissues, using exon 1 and 7 primers. Products visualized on agarose gel at low (top) and high (bottom) contrast. Note the presence of three separate products in the cortex sample corresponding to E2F1a, E2F1b, and E2F1c variants. Only E2F1a is present in the other tissues. B. PCR targeting only the E2F1b variant (exon 1 and intron 5), only detected in cortex. C. PCR for E2F1 variants as in A , using exon 4 and 7 primers. Note three bands present in the cortex sample, corresponding to E2F1a, E2F1b, and E2F1c variants. Only E2F1a was detected in all other tissues. All gels are representative of PCRs from at least n = 4 biological samples. PCRs performed on cDNA generated from DNase digested RNA. All PCR products for E2F1b and E2F1c variants were gel extracted and validated by DNA sequencing. Equal loading of RNA for cDNA synthesis and subsequent PCR reactions was confirmed by a PCR reaction for GAPDH (data not shown).
    Figure Legend Snippet: Detection of E2F1 variants in tissue A. PCR amplification of E2F1 variants in indicated tissues, using exon 1 and 7 primers. Products visualized on agarose gel at low (top) and high (bottom) contrast. Note the presence of three separate products in the cortex sample corresponding to E2F1a, E2F1b, and E2F1c variants. Only E2F1a is present in the other tissues. B. PCR targeting only the E2F1b variant (exon 1 and intron 5), only detected in cortex. C. PCR for E2F1 variants as in A , using exon 4 and 7 primers. Note three bands present in the cortex sample, corresponding to E2F1a, E2F1b, and E2F1c variants. Only E2F1a was detected in all other tissues. All gels are representative of PCRs from at least n = 4 biological samples. PCRs performed on cDNA generated from DNase digested RNA. All PCR products for E2F1b and E2F1c variants were gel extracted and validated by DNA sequencing. Equal loading of RNA for cDNA synthesis and subsequent PCR reactions was confirmed by a PCR reaction for GAPDH (data not shown).

    Techniques Used: Polymerase Chain Reaction, Amplification, Agarose Gel Electrophoresis, Variant Assay, Generated, DNA Sequencing

    26) Product Images from "Reciprocal regulation of activating and inhibitory Fc? receptors by TLR7/8 activation: Implications for tumor immunotherapy"

    Article Title: Reciprocal regulation of activating and inhibitory Fc? receptors by TLR7/8 activation: Implications for tumor immunotherapy

    Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

    doi: 10.1158/1078-0432.CCR-09-2591

    Requirement of secreted factors for R-848-mediated changes in FcγR expression. (A) PBM were pretreated with or without Brefeldin A for 30 minutes and treated for 12 hours with or without 1 µM R848. RNA was extracted and FcγR expression
    Figure Legend Snippet: Requirement of secreted factors for R-848-mediated changes in FcγR expression. (A) PBM were pretreated with or without Brefeldin A for 30 minutes and treated for 12 hours with or without 1 µM R848. RNA was extracted and FcγR expression

    Techniques Used: Expressing

    27) Product Images from "Identification of the E9^E2C cDNA and Functional Characterization of the Gene Product Reveal a New Repressor of Transcription and Replication in Cottontail Rabbit Papillomavirus"

    Article Title: Identification of the E9^E2C cDNA and Functional Characterization of the Gene Product Reveal a New Repressor of Transcription and Replication in Cottontail Rabbit Papillomavirus

    Journal: Journal of Virology

    doi: 10.1128/JVI.77.16.8736-8744.2003

    Detection of CRPV-E9^E2C transcript by reverse transcription-PCR. A total of 500 ng of RNA isolated from papillomas induced by wild-type CRPV-pLAII (WT), CRPV-E9atgmut-pLAII (E9atgmut), or CRPV-E9stop-pLAII (E9stop) was used in a reverse transcription-PCR with primers P1708 (upstream of SD 1751 ) and P3883 (downstream of SA 3714 ) and Ready-To-Go reverse transcription-PCR beads. The correct size of the cDNA fragment derived from the spliced E9^E2C transcript is shown on a 2% agarose gel. The sizes of molecular size markers are given on the right (in base pairs).
    Figure Legend Snippet: Detection of CRPV-E9^E2C transcript by reverse transcription-PCR. A total of 500 ng of RNA isolated from papillomas induced by wild-type CRPV-pLAII (WT), CRPV-E9atgmut-pLAII (E9atgmut), or CRPV-E9stop-pLAII (E9stop) was used in a reverse transcription-PCR with primers P1708 (upstream of SD 1751 ) and P3883 (downstream of SA 3714 ) and Ready-To-Go reverse transcription-PCR beads. The correct size of the cDNA fragment derived from the spliced E9^E2C transcript is shown on a 2% agarose gel. The sizes of molecular size markers are given on the right (in base pairs).

    Techniques Used: Polymerase Chain Reaction, Isolation, Derivative Assay, Agarose Gel Electrophoresis

    28) Product Images from "A Recessive Contiguous Gene Deletion of Chromosome 2p16 Associated with Cystinuria and a Mitochondrial Disease"

    Article Title: A Recessive Contiguous Gene Deletion of Chromosome 2p16 Associated with Cystinuria and a Mitochondrial Disease

    Journal: American Journal of Human Genetics

    doi:

    a, Results of PCR amplifications of the SLC3A1 exons (1–10) and an unrelated gene (N.R.). The patients’ DNA (V10 and V15 in fig. 1 a ) failed to amplify the SLC3A1 exons, whereas good amplification was observed for DNA from a parent (IV1 in fig. 1 a ) and a control. The quality of the patients’ DNA was assessed by its ability to amplify an unrelated gene. A = affected, P = parent, C = unrelated control individual, and M = molecular weight marker X of Amersham. b, Multiplex PCR assay defining the deletion borders. Affected children are indicated by blackened symbols. The PCR reaction included primers a, b, and c, as indicated in fig. 3 a. Primers’ concentrations were 1 mM for primers b and c and 0.5 mM for primer a; annealing temperature was 57°C. The 439-bp product was obtained only if a normal allele was present; the 376-bp product was obtained only if a deletion allele was present. All parents are therefore heterozygotes for the deletion and the wild-type allele. M = the molecular weight marker X of Amersham. c, Results of RT-PCR from lymphoblastoid RNA from an affected individual (A; V10 in fig. 1 a ) compared with control (C) of the SLC3A1, PP2Cβ, and KIAA0436 genes. None of these transcripts are PCR-amplified in the affected individual. The actin gene was included to assess RNA quality. Primers for the PCR were selected on different exons, to avoid amplification from residual DNA in the RNA preparation.
    Figure Legend Snippet: a, Results of PCR amplifications of the SLC3A1 exons (1–10) and an unrelated gene (N.R.). The patients’ DNA (V10 and V15 in fig. 1 a ) failed to amplify the SLC3A1 exons, whereas good amplification was observed for DNA from a parent (IV1 in fig. 1 a ) and a control. The quality of the patients’ DNA was assessed by its ability to amplify an unrelated gene. A = affected, P = parent, C = unrelated control individual, and M = molecular weight marker X of Amersham. b, Multiplex PCR assay defining the deletion borders. Affected children are indicated by blackened symbols. The PCR reaction included primers a, b, and c, as indicated in fig. 3 a. Primers’ concentrations were 1 mM for primers b and c and 0.5 mM for primer a; annealing temperature was 57°C. The 439-bp product was obtained only if a normal allele was present; the 376-bp product was obtained only if a deletion allele was present. All parents are therefore heterozygotes for the deletion and the wild-type allele. M = the molecular weight marker X of Amersham. c, Results of RT-PCR from lymphoblastoid RNA from an affected individual (A; V10 in fig. 1 a ) compared with control (C) of the SLC3A1, PP2Cβ, and KIAA0436 genes. None of these transcripts are PCR-amplified in the affected individual. The actin gene was included to assess RNA quality. Primers for the PCR were selected on different exons, to avoid amplification from residual DNA in the RNA preparation.

    Techniques Used: Polymerase Chain Reaction, Amplification, Molecular Weight, Marker, Multiplex Assay, Reverse Transcription Polymerase Chain Reaction

    29) Product Images from "MDM4 inhibition: a novel therapeutic strategy to reactivate p53 in hepatoblastoma"

    Article Title: MDM4 inhibition: a novel therapeutic strategy to reactivate p53 in hepatoblastoma

    Journal: Scientific Reports

    doi: 10.1038/s41598-021-82542-4

    Cytotoxic effects of NSC207895 are dependent on MDM4. ( a ) Immunoblotting with HepG2 and HepT1 cells transduced with MDM4 cDNA or vector control (vc) with an antibody recognizing MDM4 (04–1555, Millipore). β-Actin immunoblotting was used as a loading control. Data shown are representative of at least three independent experiments. Full length blots for data shown in a are presented in Supplementary Fig. 11 . ( b ) Bar graphs representing normalized mRNA expression of MDM4 analyzed with qPCR experiments. RNA extracted from HepG2 and HepT1 cells transduced with sh-MDM4-35 or sh-MDM4-37 was compared to that transduced with sh-GFP . ( c ) Cells transduced with MDM4 cDNA or vc were incubated with varying concentrations of NSC207895 for 48 h. MTT assays were performed at 48 h to asses viability. ( d ) Cells transduced with sh-MDM4 or control sh-GFP were grown for 120 h and MTT assays were done at 24 h intervals to assess cell number. Data shown in b, c, and d are representative of at least three independent experiments performed with three replicate wells each time. Error bars represent SD. Student’s t test * P
    Figure Legend Snippet: Cytotoxic effects of NSC207895 are dependent on MDM4. ( a ) Immunoblotting with HepG2 and HepT1 cells transduced with MDM4 cDNA or vector control (vc) with an antibody recognizing MDM4 (04–1555, Millipore). β-Actin immunoblotting was used as a loading control. Data shown are representative of at least three independent experiments. Full length blots for data shown in a are presented in Supplementary Fig. 11 . ( b ) Bar graphs representing normalized mRNA expression of MDM4 analyzed with qPCR experiments. RNA extracted from HepG2 and HepT1 cells transduced with sh-MDM4-35 or sh-MDM4-37 was compared to that transduced with sh-GFP . ( c ) Cells transduced with MDM4 cDNA or vc were incubated with varying concentrations of NSC207895 for 48 h. MTT assays were performed at 48 h to asses viability. ( d ) Cells transduced with sh-MDM4 or control sh-GFP were grown for 120 h and MTT assays were done at 24 h intervals to assess cell number. Data shown in b, c, and d are representative of at least three independent experiments performed with three replicate wells each time. Error bars represent SD. Student’s t test * P

    Techniques Used: Transduction, Plasmid Preparation, Expressing, Real-time Polymerase Chain Reaction, Incubation, MTT Assay

    Acute MDM4 inhibition with ATSP-7041 and NSC207895 lead to upregulation of p53 activity and downstream signaling. ( a ) Bar graphs representing normalized mRNA expression of p53 targets Bax , Puma , CDKN1A , and MDM2 analyzed with qPCR experiments. RNA extracted from HepG2 and HepT1 cells treated with 10 μM ATSP-7041 for 24 h was compared to that from untreated cells (0 h). Error bars represent SD. Data shown are representative of at least three independent experiments performed with three replicate wells each time. Student’s t test (two tailed) * P
    Figure Legend Snippet: Acute MDM4 inhibition with ATSP-7041 and NSC207895 lead to upregulation of p53 activity and downstream signaling. ( a ) Bar graphs representing normalized mRNA expression of p53 targets Bax , Puma , CDKN1A , and MDM2 analyzed with qPCR experiments. RNA extracted from HepG2 and HepT1 cells treated with 10 μM ATSP-7041 for 24 h was compared to that from untreated cells (0 h). Error bars represent SD. Data shown are representative of at least three independent experiments performed with three replicate wells each time. Student’s t test (two tailed) * P

    Techniques Used: Inhibition, Activity Assay, Expressing, Real-time Polymerase Chain Reaction, Two Tailed Test

    Prolonged MDM4 inhibition with ATSP-7041 and NSC207895 lead to upregulation of p53 activity and downstream signaling. ( a ) Bar graphs representing normalized mRNA expression of p53 targets Bax , Puma , CDKN1A , and MDM2 analyzed with qPCR experiments. RNA extracted from HepG2 and HepT1 cells treated with the indicated concentrations of ATSP-7041 for 48 h was compared to that from untreated cells (0 h). Error bars represent SD. Data shown are representative of at least three independent experiments performed with three replicate wells each time. Student’s t test (two tailed) * P
    Figure Legend Snippet: Prolonged MDM4 inhibition with ATSP-7041 and NSC207895 lead to upregulation of p53 activity and downstream signaling. ( a ) Bar graphs representing normalized mRNA expression of p53 targets Bax , Puma , CDKN1A , and MDM2 analyzed with qPCR experiments. RNA extracted from HepG2 and HepT1 cells treated with the indicated concentrations of ATSP-7041 for 48 h was compared to that from untreated cells (0 h). Error bars represent SD. Data shown are representative of at least three independent experiments performed with three replicate wells each time. Student’s t test (two tailed) * P

    Techniques Used: Inhibition, Activity Assay, Expressing, Real-time Polymerase Chain Reaction, Two Tailed Test

    Cytotoxic effects of NSC207895 are dependent on p53 signaling. ( a ) Immunoblotting with HepG2 and HepT1 cells transduced with sh-TP53 or control sh-Luc with an antibody recognizing p53. β-Actin immunoblotting was used as a loading control. Data shown are representative of at least three independent experiments. Full length blots for data shown in a are presented in Supplementary Fig. 10 . ( b ) Cells transduced with sh-TP53 or control sh-Luc were incubated with varying indicated concentrations of NSC207895 for 48 h. MTT assays were performed at 48 h to assess viability. ( c ) Bar graphs representing normalized mRNA expression of p53 targets Bax , Puma , CDKN1A , and MDM2 analyzed with qPCR experiments. RNA was extracted from cells transduced with sh-TP53 or control sh-Luc treated with 10 μM NSC207895 for 0 or 4 h. Expression in treated cells (4 h) was compared to that from untreated cells (0 h). Data shown in b and c are representative of at least three independent experiments performed with three replicate wells each time. Error bars represent SD. Student’s t test (two tailed) * P
    Figure Legend Snippet: Cytotoxic effects of NSC207895 are dependent on p53 signaling. ( a ) Immunoblotting with HepG2 and HepT1 cells transduced with sh-TP53 or control sh-Luc with an antibody recognizing p53. β-Actin immunoblotting was used as a loading control. Data shown are representative of at least three independent experiments. Full length blots for data shown in a are presented in Supplementary Fig. 10 . ( b ) Cells transduced with sh-TP53 or control sh-Luc were incubated with varying indicated concentrations of NSC207895 for 48 h. MTT assays were performed at 48 h to assess viability. ( c ) Bar graphs representing normalized mRNA expression of p53 targets Bax , Puma , CDKN1A , and MDM2 analyzed with qPCR experiments. RNA was extracted from cells transduced with sh-TP53 or control sh-Luc treated with 10 μM NSC207895 for 0 or 4 h. Expression in treated cells (4 h) was compared to that from untreated cells (0 h). Data shown in b and c are representative of at least three independent experiments performed with three replicate wells each time. Error bars represent SD. Student’s t test (two tailed) * P

    Techniques Used: Transduction, Incubation, MTT Assay, Expressing, Real-time Polymerase Chain Reaction, Two Tailed Test

    30) Product Images from "Posttranscriptional Regulation of HIV-1 Gene Expression during Replication and Reactivation from Latency by Nuclear Matrix Protein MATR3"

    Article Title: Posttranscriptional Regulation of HIV-1 Gene Expression during Replication and Reactivation from Latency by Nuclear Matrix Protein MATR3

    Journal: mBio

    doi: 10.1128/mBio.02158-18

    Depletion of MATR3 inhibits HIV-1 Gag expression and nuclear export of unspliced RNA. (A) Optimization of shMATR3 lentivectors. HeLa cells were transduced with lentivectors targeting MATR3 (shMATR3) or with control shRNA (shCTRL). Three days after puromycin selection, MATR3-depleted cells were harvested for immunoblotting. α-Tubulin is the protein loading control. (B) Depletion of MATR3 in Jurkat cells. Lentivectors for MATR3 depletion were used to transduce Jurkat cells, which were processed as indicated above. β-Actin is the loading control. (C) MATR3 knockdown leads to the decrease of HIV-1 Gag expression. Jurkat cells were transduced with shMATR3. Three days after puromycin selection, MATR3-depleted cells were infected with replication-competent HIV-1 NL4.3 virus and harvested 48 h postinfection for immunoblotting. β-Actin is the protein loading control. (D) MATR3 depletion leads to the decrease in the extracellular release of HIV-1 p24. MATR3-depleted Jurkat cells generated as described above were infected with HIV-1 pNL-4.3 virus, and supernatant was harvested 48 h postinfection. Virion production in the supernatant was quantified by HIV-1 p24 ELISA. Average values of three independent experiments are shown, with standard deviations (SD) and P values as described in Materials and Methods. (E) HIV-1 LTR-driven transcription is not affected by MATR3 knockdown. MATR3-depleted Jurkat cells generated as described above were infected with HIV-1 pNL-4.3 luciferase virus (pNL-4.3-R-E-luc) pseudotyped with the VSV-G envelope. Luciferase was measured 48 h postinfection. Relative luciferase expression was normalized to total protein levels as measured by Bradford assay. The results of three independent experiments are shown as mean values ± SD. (F) Nucleocytoplasmic fractionation of Jurkat cells. Following shMATR3 transduction and infection as described above, Jurkat cells were subjected to nucleocytoplasmic fractionation. The cytoplasmic marker protein Hsp90 was detected only in the cytoplasm, while the nuclear marker PARP was detected only in the nuclear fraction. MATR3 was detected only in the nucleus of shCTRL-treated cells and depleted from the nuclear extracts of cells treated with shMATR3_905 and shMATR3_906. The Coomassie blue-stained gel was used as the loading control. (G) HIV-1 unspliced RNA levels are modulated by MATR3. Quantitative analysis of unspliced HIV-1 RNA levels in Jurkat cells treated as above. Unspliced (US) RNA levels were analyzed by quantitative real-time PCR on nuclear (NF) and cytoplasmic (CF) fractions. Data were normalized to GAPDH mRNA expression and presented as fold changes compared to shCTRL. Average values of triplicate independent experiments are shown, with standard deviations (SD) and P values as described in Materials and Methods.
    Figure Legend Snippet: Depletion of MATR3 inhibits HIV-1 Gag expression and nuclear export of unspliced RNA. (A) Optimization of shMATR3 lentivectors. HeLa cells were transduced with lentivectors targeting MATR3 (shMATR3) or with control shRNA (shCTRL). Three days after puromycin selection, MATR3-depleted cells were harvested for immunoblotting. α-Tubulin is the protein loading control. (B) Depletion of MATR3 in Jurkat cells. Lentivectors for MATR3 depletion were used to transduce Jurkat cells, which were processed as indicated above. β-Actin is the loading control. (C) MATR3 knockdown leads to the decrease of HIV-1 Gag expression. Jurkat cells were transduced with shMATR3. Three days after puromycin selection, MATR3-depleted cells were infected with replication-competent HIV-1 NL4.3 virus and harvested 48 h postinfection for immunoblotting. β-Actin is the protein loading control. (D) MATR3 depletion leads to the decrease in the extracellular release of HIV-1 p24. MATR3-depleted Jurkat cells generated as described above were infected with HIV-1 pNL-4.3 virus, and supernatant was harvested 48 h postinfection. Virion production in the supernatant was quantified by HIV-1 p24 ELISA. Average values of three independent experiments are shown, with standard deviations (SD) and P values as described in Materials and Methods. (E) HIV-1 LTR-driven transcription is not affected by MATR3 knockdown. MATR3-depleted Jurkat cells generated as described above were infected with HIV-1 pNL-4.3 luciferase virus (pNL-4.3-R-E-luc) pseudotyped with the VSV-G envelope. Luciferase was measured 48 h postinfection. Relative luciferase expression was normalized to total protein levels as measured by Bradford assay. The results of three independent experiments are shown as mean values ± SD. (F) Nucleocytoplasmic fractionation of Jurkat cells. Following shMATR3 transduction and infection as described above, Jurkat cells were subjected to nucleocytoplasmic fractionation. The cytoplasmic marker protein Hsp90 was detected only in the cytoplasm, while the nuclear marker PARP was detected only in the nuclear fraction. MATR3 was detected only in the nucleus of shCTRL-treated cells and depleted from the nuclear extracts of cells treated with shMATR3_905 and shMATR3_906. The Coomassie blue-stained gel was used as the loading control. (G) HIV-1 unspliced RNA levels are modulated by MATR3. Quantitative analysis of unspliced HIV-1 RNA levels in Jurkat cells treated as above. Unspliced (US) RNA levels were analyzed by quantitative real-time PCR on nuclear (NF) and cytoplasmic (CF) fractions. Data were normalized to GAPDH mRNA expression and presented as fold changes compared to shCTRL. Average values of triplicate independent experiments are shown, with standard deviations (SD) and P values as described in Materials and Methods.

    Techniques Used: Expressing, Transduction, shRNA, Selection, Infection, Generated, Enzyme-linked Immunosorbent Assay, Luciferase, Bradford Assay, Fractionation, Marker, Staining, Real-time Polymerase Chain Reaction

    31) Product Images from "Transcription start site analysis reveals widespread divergent transcription in D. melanogaster and core promoter-encoded enhancer activities"

    Article Title: Transcription start site analysis reveals widespread divergent transcription in D. melanogaster and core promoter-encoded enhancer activities

    Journal: Nucleic Acids Research

    doi: 10.1093/nar/gky244

    DNA sequence elements impact the stability, directionality and expression strengths of regulatory elements. ( A, B ) Frequencies of RNA processing motifs (A: 5′ splice site, B: polyadenylation site) downstream of CAGE summits broken up by DHS class and strand. Vertical axes show the average number of predicted sites per bp within an increasing window size from the TSS (horizontal axis) in which the motif search was done. 0 indicates the expected hit frequency from random genomic background. ( C ) Histogram of de novo-assembled transcript counts (vertical axis), broken up by number of exons and associated DHS class. ( D ) Fraction of transcribed DHSs (vertical axis) with an identified core promoter element (TATA, Inr, DPE, or MTE) at a given position relative to the major (left panels) and minor (right panels) strand CAGE summits. ( E ) Fraction of transcribed DHSs within each DHS class (vertical axis) associated with at least one out of nine core promoter elements identified on one or both strands. In addition, the fraction of DHSs with no core promoter elements are shown (none). ( F ) Hierarchical Ward agglomerative clustering of motif match scores for the nine considered core promoter elements on major and minor strands of transcribed DHSs. Ten clusters of core promoter element compositions are shown. ( G ) DHS class enrichments, calculated as the fraction of DHSs in each DHS class associated with each core promoter element cluster versus the fraction of total transcribed DHSs, displayed in log 2 for DHS class enrichments for all core promoter clusters.
    Figure Legend Snippet: DNA sequence elements impact the stability, directionality and expression strengths of regulatory elements. ( A, B ) Frequencies of RNA processing motifs (A: 5′ splice site, B: polyadenylation site) downstream of CAGE summits broken up by DHS class and strand. Vertical axes show the average number of predicted sites per bp within an increasing window size from the TSS (horizontal axis) in which the motif search was done. 0 indicates the expected hit frequency from random genomic background. ( C ) Histogram of de novo-assembled transcript counts (vertical axis), broken up by number of exons and associated DHS class. ( D ) Fraction of transcribed DHSs (vertical axis) with an identified core promoter element (TATA, Inr, DPE, or MTE) at a given position relative to the major (left panels) and minor (right panels) strand CAGE summits. ( E ) Fraction of transcribed DHSs within each DHS class (vertical axis) associated with at least one out of nine core promoter elements identified on one or both strands. In addition, the fraction of DHSs with no core promoter elements are shown (none). ( F ) Hierarchical Ward agglomerative clustering of motif match scores for the nine considered core promoter elements on major and minor strands of transcribed DHSs. Ten clusters of core promoter element compositions are shown. ( G ) DHS class enrichments, calculated as the fraction of DHSs in each DHS class associated with each core promoter element cluster versus the fraction of total transcribed DHSs, displayed in log 2 for DHS class enrichments for all core promoter clusters.

    Techniques Used: Sequencing, Expressing

    32) Product Images from "CircAGAP1 promotes tumor progression by sponging miR-15-5p in clear cell renal cell carcinoma"

    Article Title: CircAGAP1 promotes tumor progression by sponging miR-15-5p in clear cell renal cell carcinoma

    Journal: Journal of Experimental & Clinical Cancer Research : CR

    doi: 10.1186/s13046-021-01864-3

    Expression and characterization of circAGAP1 in ccRCC. a The expression of circAGAP1 in ccRCC was examined by microarray. b The exonic information of circAGAP1 (circBase ID: hsa_circ_0058792) is demonstrated. Hsa_circ_0058792 is generated by circularization of exons 2–6 of the AGAP1 gene. The back-splicing junction was verified via Sanger sequencing. c Random hexamer or oligo (dT)18 primers were used for the reverse transcription assay. The RNA levels of circAGAP1, linear AGAP1 and GAPDH were detected by RT-qPCR in samples with RNase R (RNase R+) or without RNAse R (RNase R-) treatment. Data are presented as the means ± SEM from three independent experiments. d Expression levels of circAGAP1 in paired ccRCC and adjacent noncancerous tissues ( n = 34). e qRT-PCR analysis of circAGAP1 expression in human ccRCC cell lines (A498, ACHN, CAKI-1 and OS-RC-2) and HK2 cells. f , g qRT-PCR analysis of circAGAP1 expression in human ccRCC cells (A498, ACHN) subjected to either normoxia or hypoxia for 12 h. Data are presented as the means ± SEM from three independent experiments and are expressed as the relative fold-change over normoxic controls. * p
    Figure Legend Snippet: Expression and characterization of circAGAP1 in ccRCC. a The expression of circAGAP1 in ccRCC was examined by microarray. b The exonic information of circAGAP1 (circBase ID: hsa_circ_0058792) is demonstrated. Hsa_circ_0058792 is generated by circularization of exons 2–6 of the AGAP1 gene. The back-splicing junction was verified via Sanger sequencing. c Random hexamer or oligo (dT)18 primers were used for the reverse transcription assay. The RNA levels of circAGAP1, linear AGAP1 and GAPDH were detected by RT-qPCR in samples with RNase R (RNase R+) or without RNAse R (RNase R-) treatment. Data are presented as the means ± SEM from three independent experiments. d Expression levels of circAGAP1 in paired ccRCC and adjacent noncancerous tissues ( n = 34). e qRT-PCR analysis of circAGAP1 expression in human ccRCC cell lines (A498, ACHN, CAKI-1 and OS-RC-2) and HK2 cells. f , g qRT-PCR analysis of circAGAP1 expression in human ccRCC cells (A498, ACHN) subjected to either normoxia or hypoxia for 12 h. Data are presented as the means ± SEM from three independent experiments and are expressed as the relative fold-change over normoxic controls. * p

    Techniques Used: Expressing, Microarray, Generated, Sequencing, Random Hexamer Labeling, Quantitative RT-PCR

    circAGAP1 sponged miR-15a-5p. a The interaction between miR-15a-5p and circAGAP1 was assessed by biotin-coupled probe pull-down assay. Data are presented as the means ± SEM from three independent experiments. b Detection of colocalization of miR-15a-5p and circAGAP1 in A498 and ACHN cells by RNA-FISH assay. Nuclei were stained with DAPI (magnification, × 400). Red, miR-15a-5p; Green, circAGAP1; Blue, DAPI. c Wild-type (WT) and associated mutant (MUT) sequences of the potential miR-15a-5p binding sites in circAGAP1. The effect of the miR-15a-5p mimic on the luciferase activities of WT or MUT circAGAP1 was detected. d Expression of miR-15a-5p in ccRCC and adjacent noncancerous tissues was analyzed ( N = 25, p = 0.0008). The experiments were repeated with at least three biological replicates. ** p
    Figure Legend Snippet: circAGAP1 sponged miR-15a-5p. a The interaction between miR-15a-5p and circAGAP1 was assessed by biotin-coupled probe pull-down assay. Data are presented as the means ± SEM from three independent experiments. b Detection of colocalization of miR-15a-5p and circAGAP1 in A498 and ACHN cells by RNA-FISH assay. Nuclei were stained with DAPI (magnification, × 400). Red, miR-15a-5p; Green, circAGAP1; Blue, DAPI. c Wild-type (WT) and associated mutant (MUT) sequences of the potential miR-15a-5p binding sites in circAGAP1. The effect of the miR-15a-5p mimic on the luciferase activities of WT or MUT circAGAP1 was detected. d Expression of miR-15a-5p in ccRCC and adjacent noncancerous tissues was analyzed ( N = 25, p = 0.0008). The experiments were repeated with at least three biological replicates. ** p

    Techniques Used: Pull Down Assay, Fluorescence In Situ Hybridization, Staining, Mutagenesis, Binding Assay, Luciferase, Expressing

    33) Product Images from "Quercetin-induced ubiquitination and down-regulation of Her-2/neu"

    Article Title: Quercetin-induced ubiquitination and down-regulation of Her-2/neu

    Journal: Journal of cellular biochemistry

    doi: 10.1002/jcb.21859

    Her-2/ neu down-regulation by quercetin is not regulated at transcription level. A: SK-Br3 cells were treated with 100 μM of quercetin for the indicated times and then total RNA was extracted. Her-2/ neu mRNA levels were compared by Northern blot analysis. Ethidium bromide stained rRNA bands are shown as a loading control. B: Her-2/ neu mRNA levels were compared by real-time RT-PCR analysis using 18S rRNA as an internal control. Error bars represent standard error from the mean (SEM) for three independent experiments.
    Figure Legend Snippet: Her-2/ neu down-regulation by quercetin is not regulated at transcription level. A: SK-Br3 cells were treated with 100 μM of quercetin for the indicated times and then total RNA was extracted. Her-2/ neu mRNA levels were compared by Northern blot analysis. Ethidium bromide stained rRNA bands are shown as a loading control. B: Her-2/ neu mRNA levels were compared by real-time RT-PCR analysis using 18S rRNA as an internal control. Error bars represent standard error from the mean (SEM) for three independent experiments.

    Techniques Used: Northern Blot, Staining, Quantitative RT-PCR

    34) Product Images from "Genome-wide identification and functional analysis of ARF transcription factors in Brassica juncea var. tumida"

    Article Title: Genome-wide identification and functional analysis of ARF transcription factors in Brassica juncea var. tumida

    Journal: PLoS ONE

    doi: 10.1371/journal.pone.0232039

    Expression pattern of BjARFs . A. Expression profiles of BjARFs from RNA-seq in different tissues and cultivars. Color represents BjARF expression levels: Log2 (FPKM). The phylogenetic relationship is shown on the left. RNA expression data were selected as follows: leaf (L) of the seedling stage (SS), leaf and stem (S) of the flowing period (FP), leaf and stem of the mature period (MP) from YA1 (yonganxiaoye1), YA2 (yonganxiaoye2) and YA3 (yonganxiaoye3), respectively. B–M. Validation of candidate BjARFs using qRT-PCR, based on altered expression levels. From left to right representing seedling, leaf (VP), tumor stem (VP), tumor stem (FP), flower, and legume. Error bars show the standard error calculated from three biological replicates. Values are presented as the mean ± SEM.
    Figure Legend Snippet: Expression pattern of BjARFs . A. Expression profiles of BjARFs from RNA-seq in different tissues and cultivars. Color represents BjARF expression levels: Log2 (FPKM). The phylogenetic relationship is shown on the left. RNA expression data were selected as follows: leaf (L) of the seedling stage (SS), leaf and stem (S) of the flowing period (FP), leaf and stem of the mature period (MP) from YA1 (yonganxiaoye1), YA2 (yonganxiaoye2) and YA3 (yonganxiaoye3), respectively. B–M. Validation of candidate BjARFs using qRT-PCR, based on altered expression levels. From left to right representing seedling, leaf (VP), tumor stem (VP), tumor stem (FP), flower, and legume. Error bars show the standard error calculated from three biological replicates. Values are presented as the mean ± SEM.

    Techniques Used: Expressing, RNA Sequencing Assay, RNA Expression, Quantitative RT-PCR

    35) Product Images from "The Enterococcus faecium Enterococcal Biofilm Regulator, EbrB, Regulates the esp Operon and Is Implicated in Biofilm Formation and Intestinal Colonization"

    Article Title: The Enterococcus faecium Enterococcal Biofilm Regulator, EbrB, Regulates the esp Operon and Is Implicated in Biofilm Formation and Intestinal Colonization

    Journal: PLoS ONE

    doi: 10.1371/journal.pone.0065224

    Determination of the esp operon. (A) RT-PCR analysis on synthesized cDNA on RNA obtained from wild-type E1162 using gene specific primers (underlined). Panel 1: intergenic region esp and efmE1162_1544. Panel 2: intergenic region efmE1162_1544 and efmE1162_1543. Panel 3: intergenic region efmE1162_1543 and efmE1162_1542. Panel 4: intergenic region efmE1162_1542 and efmE1162_1541. RT-PCRs were performed on 4 biological replicates represented by lanes 1, 3, 5 and 7. Lanes 2, 4, 6, 8 represent negative controls in which incubation with reverse transcriptase was omitted. Lane 9 is the positive genomic DNA control and lane 10 negative water control. (B) Expression levels of ebrB and the esp operon in ebrB and esp complemented strains. Expression of ebrB, esp, efmE1162_1544, efmE1162_1543, efmE1162_1542 and efmE1162_1541 was analyzed using qRT-PCR on synthesized cDNA from the ebrB complemented strains (E1162▵ ebrB + ebrB and E1162▵ ebrB +pEF25) in blue and esp complemented strains (E1162▵ esp + esp and E1162▵ esp+ pEF25) in red.
    Figure Legend Snippet: Determination of the esp operon. (A) RT-PCR analysis on synthesized cDNA on RNA obtained from wild-type E1162 using gene specific primers (underlined). Panel 1: intergenic region esp and efmE1162_1544. Panel 2: intergenic region efmE1162_1544 and efmE1162_1543. Panel 3: intergenic region efmE1162_1543 and efmE1162_1542. Panel 4: intergenic region efmE1162_1542 and efmE1162_1541. RT-PCRs were performed on 4 biological replicates represented by lanes 1, 3, 5 and 7. Lanes 2, 4, 6, 8 represent negative controls in which incubation with reverse transcriptase was omitted. Lane 9 is the positive genomic DNA control and lane 10 negative water control. (B) Expression levels of ebrB and the esp operon in ebrB and esp complemented strains. Expression of ebrB, esp, efmE1162_1544, efmE1162_1543, efmE1162_1542 and efmE1162_1541 was analyzed using qRT-PCR on synthesized cDNA from the ebrB complemented strains (E1162▵ ebrB + ebrB and E1162▵ ebrB +pEF25) in blue and esp complemented strains (E1162▵ esp + esp and E1162▵ esp+ pEF25) in red.

    Techniques Used: End-sequence Profiling, Reverse Transcription Polymerase Chain Reaction, Synthesized, Incubation, Expressing, Quantitative RT-PCR

    36) Product Images from "Genome-wide characterization of microRNA in foxtail millet (Setaria italica)"

    Article Title: Genome-wide characterization of microRNA in foxtail millet (Setaria italica)

    Journal: BMC Plant Biology

    doi: 10.1186/1471-2229-13-212

    Verification and characteristics of the novel foxtail millet miRNAs (nov-sit-miRNAs). (A) The nov-sit-miRNAs were validated by stem-loop RT-PCR. The RNA used for stem-loop RT-PCR was isolated from shoots (14-day-old). (B) Nucleotide frequency of novel miRNAs.
    Figure Legend Snippet: Verification and characteristics of the novel foxtail millet miRNAs (nov-sit-miRNAs). (A) The nov-sit-miRNAs were validated by stem-loop RT-PCR. The RNA used for stem-loop RT-PCR was isolated from shoots (14-day-old). (B) Nucleotide frequency of novel miRNAs.

    Techniques Used: Reverse Transcription Polymerase Chain Reaction, Isolation

    37) Product Images from "MicroRNA-570-3p regulates HuR and cytokine expression in airway epithelial cells"

    Article Title: MicroRNA-570-3p regulates HuR and cytokine expression in airway epithelial cells

    Journal: American Journal of Clinical and Experimental Immunology

    doi:

    RNA isolation, cDNA synthesis, and quantitative real-time PCR
    Figure Legend Snippet: RNA isolation, cDNA synthesis, and quantitative real-time PCR

    Techniques Used: Isolation, Real-time Polymerase Chain Reaction

    Differential effect of miR-570-3p on mRNA stability of selected transcripts. A549 cells were transfected and treated as described previously, followed by addition of Actinomycin D and isolation of RNA at the indicated time points for qPCR analysis of
    Figure Legend Snippet: Differential effect of miR-570-3p on mRNA stability of selected transcripts. A549 cells were transfected and treated as described previously, followed by addition of Actinomycin D and isolation of RNA at the indicated time points for qPCR analysis of

    Techniques Used: Transfection, Isolation, Real-time Polymerase Chain Reaction

    38) Product Images from "TNF-? and CD8+ T Cells Mediate the Beneficial Effects of Nitric Oxide Synthase-2 Deficiency in Pulmonary Paracoccidioidomycosis"

    Article Title: TNF-? and CD8+ T Cells Mediate the Beneficial Effects of Nitric Oxide Synthase-2 Deficiency in Pulmonary Paracoccidioidomycosis

    Journal: PLoS Neglected Tropical Diseases

    doi: 10.1371/journal.pntd.0002325

    INOS −/− macrophages express high levels of TGF-β arginase1 and TNF-α. Uninfected and P. brasiliensis infected macrophages were used to characterize the expression of iNOS, ARG1, TGF-β, IL-12, TNF-α and IDO mRNA by quantitative Real-Time PCR. Total RNA was extracted using Trizol reagent, reverse transcribed, and cDNA amplified. Real-time PCR was performed using TaqMan universal master mix. Amplified products were normalized to the amount of GAPDH products from macrophages. All analyzes were done with five wells per condition in three independent experiments. The bars depict means ± SEM ** ( P
    Figure Legend Snippet: INOS −/− macrophages express high levels of TGF-β arginase1 and TNF-α. Uninfected and P. brasiliensis infected macrophages were used to characterize the expression of iNOS, ARG1, TGF-β, IL-12, TNF-α and IDO mRNA by quantitative Real-Time PCR. Total RNA was extracted using Trizol reagent, reverse transcribed, and cDNA amplified. Real-time PCR was performed using TaqMan universal master mix. Amplified products were normalized to the amount of GAPDH products from macrophages. All analyzes were done with five wells per condition in three independent experiments. The bars depict means ± SEM ** ( P

    Techniques Used: Infection, Expressing, Real-time Polymerase Chain Reaction, Amplification

    39) Product Images from "RNA-Seq-Based Analysis of Cold Shock Response in Thermoanaerobacter tengcongensis, a Bacterium Harboring a Single Cold Shock Protein Encoding Gene"

    Article Title: RNA-Seq-Based Analysis of Cold Shock Response in Thermoanaerobacter tengcongensis, a Bacterium Harboring a Single Cold Shock Protein Encoding Gene

    Journal: PLoS ONE

    doi: 10.1371/journal.pone.0093289

    Validation of differentially expressed genes by real-time PCR. Comparison of RNA-seq and real-time PCR measures of changes in expression of eutD (encoding phosphotransacetylase), rpmE (50S ribosomal protein L31), acpP (acyl carrier protein), tte0510 (hypothetical protein), tte2654 (hypothetical protein), tte0106 (hypothetical protein), dnaA (chromosome replication initiator DnaA), tte1002 (hypothetical protein), pspf4 (a transcriptional regulator), and cspC (cold shock protein). All data are shown as means ± SD (n = 3).
    Figure Legend Snippet: Validation of differentially expressed genes by real-time PCR. Comparison of RNA-seq and real-time PCR measures of changes in expression of eutD (encoding phosphotransacetylase), rpmE (50S ribosomal protein L31), acpP (acyl carrier protein), tte0510 (hypothetical protein), tte2654 (hypothetical protein), tte0106 (hypothetical protein), dnaA (chromosome replication initiator DnaA), tte1002 (hypothetical protein), pspf4 (a transcriptional regulator), and cspC (cold shock protein). All data are shown as means ± SD (n = 3).

    Techniques Used: Real-time Polymerase Chain Reaction, RNA Sequencing Assay, Expressing

    40) Product Images from "Notch Signaling Activation Suppresses v-Src-Induced Transformation of Neural Cells by Restoring TGF-?-Mediated Differentiation"

    Article Title: Notch Signaling Activation Suppresses v-Src-Induced Transformation of Neural Cells by Restoring TGF-?-Mediated Differentiation

    Journal: PLoS ONE

    doi: 10.1371/journal.pone.0013572

    TGF-β3 expression is controlled by a positive feed-back loop. QPCR analysis of TGF-β-3 mRNA levels in (A) QNR/v-src ts treated with 2 µg/ml of recombinant TGF-β3 or (B) QNR/v-Src ts /ICN cells at 37°C incubated with increasing doses of SB431542 during 24 hrs. After reverse transcription of 1 µg of RNA, TGF-β3 cDNA were amplified by QPCR. Results were normalized based on HPRT and TBP transcript levels and presented in relative arbitrary units using values obtained for untreated cells as reference equal to 1. Each bar represents the mean −/+ S.E. of three experiments.
    Figure Legend Snippet: TGF-β3 expression is controlled by a positive feed-back loop. QPCR analysis of TGF-β-3 mRNA levels in (A) QNR/v-src ts treated with 2 µg/ml of recombinant TGF-β3 or (B) QNR/v-Src ts /ICN cells at 37°C incubated with increasing doses of SB431542 during 24 hrs. After reverse transcription of 1 µg of RNA, TGF-β3 cDNA were amplified by QPCR. Results were normalized based on HPRT and TBP transcript levels and presented in relative arbitrary units using values obtained for untreated cells as reference equal to 1. Each bar represents the mean −/+ S.E. of three experiments.

    Techniques Used: Expressing, Real-time Polymerase Chain Reaction, Recombinant, Incubation, Amplification

    TGF-β3 mRNA is upregulated in QNR/v-src ts /ICN cells. QNR/v-src ts and QNR/v-src ts /ICN cells were incubated 72 hrs at 37°C or 41°C before extraction of total RNA. After reverse transcription of 1 µg of RNA, TGF-β3 cDNA was amplified by QPCR using specific primers ( Table 1 ) Results were normalized based on HPRT and TBP transcript levels and presented in relative arbitrary units. Normalized TGF-β3 mRNA levels detected in QNR/v-src ts cells at 37°C were used as reference equal to 1. Each bar represents the mean -/+ S.E. of experiments realized on 3 different cultures per cell type.
    Figure Legend Snippet: TGF-β3 mRNA is upregulated in QNR/v-src ts /ICN cells. QNR/v-src ts and QNR/v-src ts /ICN cells were incubated 72 hrs at 37°C or 41°C before extraction of total RNA. After reverse transcription of 1 µg of RNA, TGF-β3 cDNA was amplified by QPCR using specific primers ( Table 1 ) Results were normalized based on HPRT and TBP transcript levels and presented in relative arbitrary units. Normalized TGF-β3 mRNA levels detected in QNR/v-src ts cells at 37°C were used as reference equal to 1. Each bar represents the mean -/+ S.E. of experiments realized on 3 different cultures per cell type.

    Techniques Used: Incubation, Amplification, Real-time Polymerase Chain Reaction

    Related Articles

    Amplification:

    Article Title: The protein modifier SUMO is critical for Arabidopsis shoot meristem maintenance at warmer ambient temperatures
    Article Snippet: .. A total of 100 ng total RNA was amplified using the GeneChip WT PLUS Reagent Kit (Affymetrix) to generate biotinylated sense-strand DNA targets. ..

    Article Title: Inflammasomes are activated in response to SARS-CoV-2 infection and are associated with COVID-19 severity in patients
    Article Snippet: .. A total of 100 ng of RNA was used for genome amplification, adding specific primers (20 µM), and probe (5 µM), and with TaqPath 1-Step quantitative RT-PCR Master Mix (Applied Biosystems), with the following parameters: 25°C for 2 min, 50°C for 15 min, and 95°C for 2 min, followed by 45 cycles of 94°C for 5 s and 60°C for 30 s. Primers used were the following: N2 forward: 5′-TTA​CAA​ACA​TTG​GCC​GCA​AA-3′, N2 reverse: 5′-GCG​CGA​CAT​TCC​GAA​GAA-3′; N2 probe: 5′-FAM-ACAATTTGCCCCCAGCGCTTCAG-BHQ1-3′ ( ); E forward: 5′-ACA​GGT​ACG​TTA​ATA​GTT​AAT​AGC​GT-3′, E reverse: 5′-ATA​TTG​CAG​CAG​TAC​GCA​CAC​A-3′; E probe: 5′-AM-ACACTAGCCATCCTTACTGCGCTTCG-BHQ-1-3′ ( ); RNase-P forward: 5′-AGA​TTT​GGA​CCT​GCG​AGC​G-3′, RNase-P reverse: 5′-GAG​CGG​CTG​TCT​CCA​CAA​GT-3′; and RNase-P probe: 5′-FAM-TTCTGACCTGAAGGCTCTGCGCG-BHQ-1-3′ ( ). ..

    Quantitative RT-PCR:

    Article Title: Inflammasomes are activated in response to SARS-CoV-2 infection and are associated with COVID-19 severity in patients
    Article Snippet: .. A total of 100 ng of RNA was used for genome amplification, adding specific primers (20 µM), and probe (5 µM), and with TaqPath 1-Step quantitative RT-PCR Master Mix (Applied Biosystems), with the following parameters: 25°C for 2 min, 50°C for 15 min, and 95°C for 2 min, followed by 45 cycles of 94°C for 5 s and 60°C for 30 s. Primers used were the following: N2 forward: 5′-TTA​CAA​ACA​TTG​GCC​GCA​AA-3′, N2 reverse: 5′-GCG​CGA​CAT​TCC​GAA​GAA-3′; N2 probe: 5′-FAM-ACAATTTGCCCCCAGCGCTTCAG-BHQ1-3′ ( ); E forward: 5′-ACA​GGT​ACG​TTA​ATA​GTT​AAT​AGC​GT-3′, E reverse: 5′-ATA​TTG​CAG​CAG​TAC​GCA​CAC​A-3′; E probe: 5′-AM-ACACTAGCCATCCTTACTGCGCTTCG-BHQ-1-3′ ( ); RNase-P forward: 5′-AGA​TTT​GGA​CCT​GCG​AGC​G-3′, RNase-P reverse: 5′-GAG​CGG​CTG​TCT​CCA​CAA​GT-3′; and RNase-P probe: 5′-FAM-TTCTGACCTGAAGGCTCTGCGCG-BHQ-1-3′ ( ). ..

    Transfection:

    Article Title: Severe Congenital Hypothyroidism Due to a Novel Deep Intronic Mutation in the TSH Receptor Gene Causing Intron Retention
    Article Snippet: .. Two days after transfection, RNA was extracted from cells using Trizol Reagent (Life Technologies), according to the manufacturer’s protocol. ..

    Isolation:

    Article Title: The deubiquitylase USP9X controls ribosomal stalling
    Article Snippet: .. RNA isolation and reverse transcription quantitative PCR Total RNA was isolated from HCT116, HCT116 USP9X− /0 , Flp-In 293 Trex K(AAA) 21 WT, and Flp-In 293 Trex K(AAA) 21 ZNF598 knockout (KO) using the Qiagen RNA extraction kit (74106). cDNA was generated using 1 µg RNA and the Thermo Scientific RevertAir H Minus reverse transcription (Thermo Fisher Scientific; 11541515) supplemented with RNasin (Promega; N251S), PCR nucleotide mix (Promega; U144B) and oligo (dT) 15 Primer (Promega; C1101). ..

    Article Title: The protein modifier SUMO is critical for Arabidopsis shoot meristem maintenance at warmer ambient temperatures
    Article Snippet: .. Gene expression quantification For the gene expression analysis, total RNA was isolated using TRIzol Reagent (ThermoFisher) according to the suppliers’ instructions. ..

    Real-time Polymerase Chain Reaction:

    Article Title: The deubiquitylase USP9X controls ribosomal stalling
    Article Snippet: .. RNA isolation and reverse transcription quantitative PCR Total RNA was isolated from HCT116, HCT116 USP9X− /0 , Flp-In 293 Trex K(AAA) 21 WT, and Flp-In 293 Trex K(AAA) 21 ZNF598 knockout (KO) using the Qiagen RNA extraction kit (74106). cDNA was generated using 1 µg RNA and the Thermo Scientific RevertAir H Minus reverse transcription (Thermo Fisher Scientific; 11541515) supplemented with RNasin (Promega; N251S), PCR nucleotide mix (Promega; U144B) and oligo (dT) 15 Primer (Promega; C1101). ..

    Article Title: Induction of spontaneous human neocentromere formation and long-term maturation
    Article Snippet: .. The residual DNA was removed with DNase I (RNase-free) from NEB at 30 C for 30 min before purification with RNeasy Mini kit (QIAGEN) following the manufacturer’s instructions. cDNA was prepared from 2 µg RNA using a High-Capacity RNA-to-cDNA Kit (Applied Biosystems), and the libraries were diluted five times before quantitative PCR measurements. ..

    Knock-Out:

    Article Title: The deubiquitylase USP9X controls ribosomal stalling
    Article Snippet: .. RNA isolation and reverse transcription quantitative PCR Total RNA was isolated from HCT116, HCT116 USP9X− /0 , Flp-In 293 Trex K(AAA) 21 WT, and Flp-In 293 Trex K(AAA) 21 ZNF598 knockout (KO) using the Qiagen RNA extraction kit (74106). cDNA was generated using 1 µg RNA and the Thermo Scientific RevertAir H Minus reverse transcription (Thermo Fisher Scientific; 11541515) supplemented with RNasin (Promega; N251S), PCR nucleotide mix (Promega; U144B) and oligo (dT) 15 Primer (Promega; C1101). ..

    RNA Extraction:

    Article Title: The deubiquitylase USP9X controls ribosomal stalling
    Article Snippet: .. RNA isolation and reverse transcription quantitative PCR Total RNA was isolated from HCT116, HCT116 USP9X− /0 , Flp-In 293 Trex K(AAA) 21 WT, and Flp-In 293 Trex K(AAA) 21 ZNF598 knockout (KO) using the Qiagen RNA extraction kit (74106). cDNA was generated using 1 µg RNA and the Thermo Scientific RevertAir H Minus reverse transcription (Thermo Fisher Scientific; 11541515) supplemented with RNasin (Promega; N251S), PCR nucleotide mix (Promega; U144B) and oligo (dT) 15 Primer (Promega; C1101). ..

    Generated:

    Article Title: The deubiquitylase USP9X controls ribosomal stalling
    Article Snippet: .. RNA isolation and reverse transcription quantitative PCR Total RNA was isolated from HCT116, HCT116 USP9X− /0 , Flp-In 293 Trex K(AAA) 21 WT, and Flp-In 293 Trex K(AAA) 21 ZNF598 knockout (KO) using the Qiagen RNA extraction kit (74106). cDNA was generated using 1 µg RNA and the Thermo Scientific RevertAir H Minus reverse transcription (Thermo Fisher Scientific; 11541515) supplemented with RNasin (Promega; N251S), PCR nucleotide mix (Promega; U144B) and oligo (dT) 15 Primer (Promega; C1101). ..

    Polymerase Chain Reaction:

    Article Title: The deubiquitylase USP9X controls ribosomal stalling
    Article Snippet: .. RNA isolation and reverse transcription quantitative PCR Total RNA was isolated from HCT116, HCT116 USP9X− /0 , Flp-In 293 Trex K(AAA) 21 WT, and Flp-In 293 Trex K(AAA) 21 ZNF598 knockout (KO) using the Qiagen RNA extraction kit (74106). cDNA was generated using 1 µg RNA and the Thermo Scientific RevertAir H Minus reverse transcription (Thermo Fisher Scientific; 11541515) supplemented with RNasin (Promega; N251S), PCR nucleotide mix (Promega; U144B) and oligo (dT) 15 Primer (Promega; C1101). ..

    Article Title: Severe Congenital Hypothyroidism Due to a Novel Deep Intronic Mutation in the TSH Receptor Gene Causing Intron Retention
    Article Snippet: .. Complementary DNA was reverse transcribed from RNA using RevertAid H minus reverse transcriptase, and polymerase chain reaction (PCR) was performed using Phusion High-Fidelity DNA polymerase (Life Technologies, California, Carlsbad). ..

    Expressing:

    Article Title: The protein modifier SUMO is critical for Arabidopsis shoot meristem maintenance at warmer ambient temperatures
    Article Snippet: .. Gene expression quantification For the gene expression analysis, total RNA was isolated using TRIzol Reagent (ThermoFisher) according to the suppliers’ instructions. ..

    Purification:

    Article Title: Induction of spontaneous human neocentromere formation and long-term maturation
    Article Snippet: .. The residual DNA was removed with DNase I (RNase-free) from NEB at 30 C for 30 min before purification with RNeasy Mini kit (QIAGEN) following the manufacturer’s instructions. cDNA was prepared from 2 µg RNA using a High-Capacity RNA-to-cDNA Kit (Applied Biosystems), and the libraries were diluted five times before quantitative PCR measurements. ..

    Similar Products

  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 97
    Thermo Fisher rna isolation
    Expression of FSIP1 in bladder cancer cell lines and human bladder tumor tissues. Notes: ( A , B ) Western blotting analysis (16 paired) showed that the expression of FSIP1 in BTs was significantly higher than that in matched ANTs ( P =0.009). ( C ) Western blotting analysis showed that FSIP1 protein expressions were significantly increased in three human bladder cancer cell lines (5637, BIU-87, and T24 in particular), compared with normal human urothelium cells SV-HUC-1. ( D ) Quantitative real-time <t>PCR</t> analysis showed an increased messenger <t>RNA</t> expression of FSIP1 in BTs as compared with ANTs (n=10, P =0.012). Abbreviations: ANTs, adjacent noncancerous tissues; BTs, bladder tumor tissues; FSIP1, fibrous sheath interacting protein 1; PCR, polymerase chain reaction.
    Rna Isolation, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rna isolation/product/Thermo Fisher
    Average 97 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    rna isolation - by Bioz Stars, 2021-09
    97/100 stars
      Buy from Supplier

    97
    Thermo Fisher dna rna
    Detection of mouse S15 expression from formalin-fixed, paraffin-embedded mouse tissue. PCR amplification was performed by using cDNA prepared from the following: fresh tissue (lane 3), germfree tissue that was fixed for 1.5 h (lane 5), and C. albicans -infected tissue that was fixed for 1.5 h (lane 7) or 72 h (lane 9). To test for the presence of contaminating <t>DNA,</t> PCR amplification was also performed by using <t>RNA</t> extracted from the following: fresh tissue (lane 2), uninfected tissue that was fixed for 1.5 h (lane 4), and C. albicans -infected tissue that was fixed for 1.5 h (lane 6) or 72 h (lane 8). The negative control PCR lacked template (lane 1). Lane M, 100-bp DNA ladder.
    Dna Rna, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/dna rna/product/Thermo Fisher
    Average 97 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    dna rna - by Bioz Stars, 2021-09
    97/100 stars
      Buy from Supplier

    93
    Thermo Fisher bone marrow cd138 fraction cd138 fraction or total
    Persistence of HIV Env-Specific Plasmablast Lineages in the BM LLPC (A) Representative Elispot of BM <t>CD138</t> + LLPC for gp120, influenza, and total IgG ASCs. (B) Summary of instances of gp120 + plasmablast-derived mAb lineages identified in BM. PB, plasmablast. (C–E) Phylogenic analysis and alignments of 1105E9 (C), 1098D3/F3 (D), and 1098C4/B8 (E) lineages. Lineage members defined as same heavy-chain V and J gene usage, HCDR3 length, and R85% HCDR3 similarity. Red-outlined regions were analyzed for isotype usage, and those for which substantial non-IgG1 sequences were observed have an associated pie chart of isotype distribution. The germline sequence is represented by the green diamond and the mAb sequences are represented by the blue square. Alignments depict germline, mAb, and CD138 + LLPC derived sequences. The red circle (C and D) indicates the position of shared identical mutation from germline and the orange circle (E) indicates shared mutation from germline.
    Bone Marrow Cd138 Fraction Cd138 Fraction Or Total, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/bone marrow cd138 fraction cd138 fraction or total/product/Thermo Fisher
    Average 93 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    bone marrow cd138 fraction cd138 fraction or total - by Bioz Stars, 2021-09
    93/100 stars
      Buy from Supplier

    99
    Thermo Fisher rna
    In vitro selection of <t>RNA-BP</t> cDNAs by using <t>T7</t> phage display. An RNA-BP cDNA is inserted into a T7 cloning vector and packaged in a phage capsid to generate a recombinant phage in which the RNA-BP is displayed on the surface as a carboxyl-terminal fusion to the T7 capsid protein 10B. The resulting phage is allowed to bind to the RNA bait, which itself is annealed to a biotinylated DNA oligonucleotide. RNA-bound T7 phage are captured on streptavidin-coated paramagnetic beads, separated from other members of the phage mixture with a magnet, and used to infect E. coli without prior release from the beads. After replication, the phage progeny can be subjected to additional rounds of selection.
    Rna, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rna/product/Thermo Fisher
    Average 99 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    rna - by Bioz Stars, 2021-09
    99/100 stars
      Buy from Supplier

    Image Search Results


    Expression of FSIP1 in bladder cancer cell lines and human bladder tumor tissues. Notes: ( A , B ) Western blotting analysis (16 paired) showed that the expression of FSIP1 in BTs was significantly higher than that in matched ANTs ( P =0.009). ( C ) Western blotting analysis showed that FSIP1 protein expressions were significantly increased in three human bladder cancer cell lines (5637, BIU-87, and T24 in particular), compared with normal human urothelium cells SV-HUC-1. ( D ) Quantitative real-time PCR analysis showed an increased messenger RNA expression of FSIP1 in BTs as compared with ANTs (n=10, P =0.012). Abbreviations: ANTs, adjacent noncancerous tissues; BTs, bladder tumor tissues; FSIP1, fibrous sheath interacting protein 1; PCR, polymerase chain reaction.

    Journal: OncoTargets and therapy

    Article Title: Fibrous sheath interacting protein 1 overexpression is associated with unfavorable prognosis in bladder cancer: a potential therapeutic target

    doi: 10.2147/OTT.S143491

    Figure Lengend Snippet: Expression of FSIP1 in bladder cancer cell lines and human bladder tumor tissues. Notes: ( A , B ) Western blotting analysis (16 paired) showed that the expression of FSIP1 in BTs was significantly higher than that in matched ANTs ( P =0.009). ( C ) Western blotting analysis showed that FSIP1 protein expressions were significantly increased in three human bladder cancer cell lines (5637, BIU-87, and T24 in particular), compared with normal human urothelium cells SV-HUC-1. ( D ) Quantitative real-time PCR analysis showed an increased messenger RNA expression of FSIP1 in BTs as compared with ANTs (n=10, P =0.012). Abbreviations: ANTs, adjacent noncancerous tissues; BTs, bladder tumor tissues; FSIP1, fibrous sheath interacting protein 1; PCR, polymerase chain reaction.

    Article Snippet: RNA isolation and quantitative real-time PCR Total RNA was isolated from tissue specimens or cultured cells using TRIzol reagent (Invitrogen) according to the instructions of the manufacturers.

    Techniques: Expressing, Western Blot, Real-time Polymerase Chain Reaction, RNA Expression, Polymerase Chain Reaction

    Detection of mouse S15 expression from formalin-fixed, paraffin-embedded mouse tissue. PCR amplification was performed by using cDNA prepared from the following: fresh tissue (lane 3), germfree tissue that was fixed for 1.5 h (lane 5), and C. albicans -infected tissue that was fixed for 1.5 h (lane 7) or 72 h (lane 9). To test for the presence of contaminating DNA, PCR amplification was also performed by using RNA extracted from the following: fresh tissue (lane 2), uninfected tissue that was fixed for 1.5 h (lane 4), and C. albicans -infected tissue that was fixed for 1.5 h (lane 6) or 72 h (lane 8). The negative control PCR lacked template (lane 1). Lane M, 100-bp DNA ladder.

    Journal: Journal of Clinical Microbiology

    Article Title: Detection of Candida albicans mRNA from Formalin-Fixed, Paraffin-Embedded Mouse Tissues by Nested Reverse Transcription-PCR

    doi: 10.1128/JCM.41.2.831-834.2003

    Figure Lengend Snippet: Detection of mouse S15 expression from formalin-fixed, paraffin-embedded mouse tissue. PCR amplification was performed by using cDNA prepared from the following: fresh tissue (lane 3), germfree tissue that was fixed for 1.5 h (lane 5), and C. albicans -infected tissue that was fixed for 1.5 h (lane 7) or 72 h (lane 9). To test for the presence of contaminating DNA, PCR amplification was also performed by using RNA extracted from the following: fresh tissue (lane 2), uninfected tissue that was fixed for 1.5 h (lane 4), and C. albicans -infected tissue that was fixed for 1.5 h (lane 6) or 72 h (lane 8). The negative control PCR lacked template (lane 1). Lane M, 100-bp DNA ladder.

    Article Snippet: Positive controls included 10 pg of genomic DNA/RNA prepared from fresh cultures of C. albicans or RNA prepared from fresh tissue (Ambion).

    Techniques: Expressing, Formalin-fixed Paraffin-Embedded, Polymerase Chain Reaction, Amplification, Infection, Negative Control

    Detection of C. albicans gene expression from formalin-fixed, paraffin-embedded mouse tissue. Nested PCR amplification was performed with EFB1 (A) or SAP9 (B) primers. PCR amplification was performed by using cDNA prepared from the following: uninfected tissue that was fixed for 1.5 h (lane 4) and C. albicans -infected tissue that was fixed for 1.5 h (lane 6) or 72 h (lane 8). To test for the presence of contaminating DNA, PCR amplification was also performed by using RNA extracted from uninfected tissue (lane 3) and C. albicans -infected tissue that was fixed for 1.5 h (lane 5) or 72 h (lane 7). The negative control PCR lacked template (lane 1), while the positive control PCR contained 10 pg of C. albicans genomic DNA (lane 2). Lane M, 100-bp DNA ladder.

    Journal: Journal of Clinical Microbiology

    Article Title: Detection of Candida albicans mRNA from Formalin-Fixed, Paraffin-Embedded Mouse Tissues by Nested Reverse Transcription-PCR

    doi: 10.1128/JCM.41.2.831-834.2003

    Figure Lengend Snippet: Detection of C. albicans gene expression from formalin-fixed, paraffin-embedded mouse tissue. Nested PCR amplification was performed with EFB1 (A) or SAP9 (B) primers. PCR amplification was performed by using cDNA prepared from the following: uninfected tissue that was fixed for 1.5 h (lane 4) and C. albicans -infected tissue that was fixed for 1.5 h (lane 6) or 72 h (lane 8). To test for the presence of contaminating DNA, PCR amplification was also performed by using RNA extracted from uninfected tissue (lane 3) and C. albicans -infected tissue that was fixed for 1.5 h (lane 5) or 72 h (lane 7). The negative control PCR lacked template (lane 1), while the positive control PCR contained 10 pg of C. albicans genomic DNA (lane 2). Lane M, 100-bp DNA ladder.

    Article Snippet: Positive controls included 10 pg of genomic DNA/RNA prepared from fresh cultures of C. albicans or RNA prepared from fresh tissue (Ambion).

    Techniques: Expressing, Formalin-fixed Paraffin-Embedded, Nested PCR, Amplification, Polymerase Chain Reaction, Infection, Negative Control, Positive Control

    Persistence of HIV Env-Specific Plasmablast Lineages in the BM LLPC (A) Representative Elispot of BM CD138 + LLPC for gp120, influenza, and total IgG ASCs. (B) Summary of instances of gp120 + plasmablast-derived mAb lineages identified in BM. PB, plasmablast. (C–E) Phylogenic analysis and alignments of 1105E9 (C), 1098D3/F3 (D), and 1098C4/B8 (E) lineages. Lineage members defined as same heavy-chain V and J gene usage, HCDR3 length, and R85% HCDR3 similarity. Red-outlined regions were analyzed for isotype usage, and those for which substantial non-IgG1 sequences were observed have an associated pie chart of isotype distribution. The germline sequence is represented by the green diamond and the mAb sequences are represented by the blue square. Alignments depict germline, mAb, and CD138 + LLPC derived sequences. The red circle (C and D) indicates the position of shared identical mutation from germline and the orange circle (E) indicates shared mutation from germline.

    Journal: Cell reports medicine

    Article Title: Persistence of HIV-1 Env-Specific Plasmablast Lineages in Plasma Cells after Vaccination in Humans

    doi: 10.1016/j.xcrm.2020.100015

    Figure Lengend Snippet: Persistence of HIV Env-Specific Plasmablast Lineages in the BM LLPC (A) Representative Elispot of BM CD138 + LLPC for gp120, influenza, and total IgG ASCs. (B) Summary of instances of gp120 + plasmablast-derived mAb lineages identified in BM. PB, plasmablast. (C–E) Phylogenic analysis and alignments of 1105E9 (C), 1098D3/F3 (D), and 1098C4/B8 (E) lineages. Lineage members defined as same heavy-chain V and J gene usage, HCDR3 length, and R85% HCDR3 similarity. Red-outlined regions were analyzed for isotype usage, and those for which substantial non-IgG1 sequences were observed have an associated pie chart of isotype distribution. The germline sequence is represented by the green diamond and the mAb sequences are represented by the blue square. Alignments depict germline, mAb, and CD138 + LLPC derived sequences. The red circle (C and D) indicates the position of shared identical mutation from germline and the orange circle (E) indicates shared mutation from germline.

    Article Snippet: VH Next-Generational SequencingFor the Ig VH sequencing library preparation, PBMCs and plasmablasts were collected 7 days post final vaccination and bone marrow (CD138+ fraction, CD138- fraction or total) and peripheral blood B cells were collected ~7 months post final vaccination.

    Techniques: Enzyme-linked Immunospot, Derivative Assay, Sequencing, Mutagenesis

    In vitro selection of RNA-BP cDNAs by using T7 phage display. An RNA-BP cDNA is inserted into a T7 cloning vector and packaged in a phage capsid to generate a recombinant phage in which the RNA-BP is displayed on the surface as a carboxyl-terminal fusion to the T7 capsid protein 10B. The resulting phage is allowed to bind to the RNA bait, which itself is annealed to a biotinylated DNA oligonucleotide. RNA-bound T7 phage are captured on streptavidin-coated paramagnetic beads, separated from other members of the phage mixture with a magnet, and used to infect E. coli without prior release from the beads. After replication, the phage progeny can be subjected to additional rounds of selection.

    Journal: Proceedings of the National Academy of Sciences of the United States of America

    Article Title: T7 phage display: A novel genetic selection system for cloning RNA-binding proteins from cDNA libraries

    doi: 10.1073/pnas.211439598

    Figure Lengend Snippet: In vitro selection of RNA-BP cDNAs by using T7 phage display. An RNA-BP cDNA is inserted into a T7 cloning vector and packaged in a phage capsid to generate a recombinant phage in which the RNA-BP is displayed on the surface as a carboxyl-terminal fusion to the T7 capsid protein 10B. The resulting phage is allowed to bind to the RNA bait, which itself is annealed to a biotinylated DNA oligonucleotide. RNA-bound T7 phage are captured on streptavidin-coated paramagnetic beads, separated from other members of the phage mixture with a magnet, and used to infect E. coli without prior release from the beads. After replication, the phage progeny can be subjected to additional rounds of selection.

    Article Snippet: RNA was synthesized with a T7-MEGAshortscript kit (Ambion, Austin, TX), using DNA templates linearized with Ava I and a trace amount of [α-32 P]CTP to aid in visualization of RNA bands.

    Techniques: In Vitro, Selection, Clone Assay, Plasmid Preparation, Recombinant

    RNA stability in phage lysates generated from different E. coli host strains. Radiolabeled U1hpII RNA (5 pmol) was mixed with either of two T7 phage lysates (5 × 10 9 pfu) prepared from E. coli BLT5615 or RNA5615 (an isogenic strain deficient in RNase I). After incubation at room temperature for the times indicated, RNA samples were analyzed by electrophoresis on a nondenaturing polyacrylamide gel.

    Journal: Proceedings of the National Academy of Sciences of the United States of America

    Article Title: T7 phage display: A novel genetic selection system for cloning RNA-binding proteins from cDNA libraries

    doi: 10.1073/pnas.211439598

    Figure Lengend Snippet: RNA stability in phage lysates generated from different E. coli host strains. Radiolabeled U1hpII RNA (5 pmol) was mixed with either of two T7 phage lysates (5 × 10 9 pfu) prepared from E. coli BLT5615 or RNA5615 (an isogenic strain deficient in RNase I). After incubation at room temperature for the times indicated, RNA samples were analyzed by electrophoresis on a nondenaturing polyacrylamide gel.

    Article Snippet: RNA was synthesized with a T7-MEGAshortscript kit (Ambion, Austin, TX), using DNA templates linearized with Ava I and a trace amount of [α-32 P]CTP to aid in visualization of RNA bands.

    Techniques: Generated, Incubation, Electrophoresis